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1.  Abstract 
DNA double strand breaks are potent inducers of cell cycle checkpoints, DNA 
damage response (DDR) signalling and repair pathways. Ionizing radiation (IR) 
efficiently induces DSBs. G2-M checkpoint activation delays/stops cell division to 
facilitate repair of these lethal lesions. According to the classical view proteins of 
PI3K kinase family ATM and ATR have been shown to be the key players in the 
activation of this checkpoint. In higher eukaryotes, two main repair pathways named 
NHEJ and HRR are responsible for the repair of DSBs. 
For many years, HRR has been considered to be a minor pathway of DSB repair in 
higher eukaryotes. This opinion is based on the fact that none of the cell lines 
deficient in important HRR genes displays obvious DSB repair defects although they 
are clearly radiosensitive to killing. It is therefore thought that in higher eukaryotes IR 
induced DSB repair is practically exclusively undertaken by the D-NHEJ pathway; on 
the other hand the role of HRR is only evident on the repair of I-SceI induced site 
directed DSBs in integrated genomic loci. Thus, how HRR contributes to the repair of 
IR induced DSBs remains unknown.  
In the work presented here, we study the repair of IR induced DSBs through their 
transformation into G2-chromosomal breaks. Our results show the direct involvement 
of HRR in the repair of a subset of IR induced DSBs which are associated with the 
formation of G2-chromosomal breaks. The D-NHEJ repair pathway does not seem to 
play a role in the repair of these breaks. 
Our results also demonstrate that HRR is a key player in the activation and 
maintenance of the G2-checkpoint. We employed flow cytometry based 
determination of mitotic index after exposure to 1Gy X-rays using phosphorylated 
histone-H3 as a marker. Chinese hamster cells deficient in RAD51 paralogs 
RAD51B, RAD51C, RAD51D, XRCC2 and XRCC3 show a remarkable defect in G2-
checkpoint activation, while cells deficient in NHEJ components KU80, DNA-PKcs 
and XRCC4 show strong G2- checkpoint activation when compared to the wild type 
cells.  
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This is, to our knowledge, the first report implicating HRR in the repair of a subset of 
DSBs with the potential of forming chromosome breaks, as well as in the 
development and maintenance of DNA damage induced cell cycle checkpoints.  
Key words: Ionizing radiation, DNA-double strand break, D-NHEJ, HRR, G2-
checkpoint, Chromatid breaks  
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2.  Introduction 
2.1  Ionizing radiation and induction of double strand breaks  
Ionizing radiation (IR) consists of subatomic particles and electromagnetic waves 
which carry enough energy to kick out electrons from atoms or molecules. X-rays and 
gamma rays are electromagnetic waves, whereas neutrons, electrons and protons 
are particulate. Particulate radiations tend to be more densely ionizing. The energy 
deposition in tissues and cell culture systems varies considerably depending not only 
on the type of radiation but also on the energy of the radiation (1). Linear energy 
transfer (LET) is a measure of the energy transferred to per unit distance of material 
as an ionizing particle travels through it. The particles which are slow moving i.e. 
alpha particles have higher LET than X-rays or gamma-rays. It is clear that between 
the initial physical processes and the eventual biological outcome, chemical reactions 
of free radicals and ion radicals are involved (2). At the molecular level, energy 
deposition by IR is non homogenous. When cells are exposed to ionizing radiation, 
radiochemical damage can occur either by direct action or indirect action. Direct 
action occurs on the DNA when alpha particles, beta particles or x-rays create ions 
on it, which physically break the sugar phosphate backbone or damage bases 
(Figure 2.1a, page 4). The indirect action occurs through generation of hydroxyl 
radicals by radiation in the surrounding water, which then damages the DNA (Figure 
2.1b, page 4). The indirect effect is responsible for the majority of damage causing 
the more severe biological effect of IR (3). Radiation is measured in the SI units of 
Gray (Gy) describing the amount of energy absorbed by a unit of mass. The unit of 1 
Gy equals one Joule of energy absorbed by one kg of mass (1J/kg). 
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Figure 2.1a  
                                                
                                          
 
 Indirect Action 
                                   
 Figure 2.1b 
(Pictures opted from www.cna.ca/curriculum/cna_bio_effects_rad/dir...) 
 
Both particulate and electromagnetic radiations can cause direct damage. However, 
heavily charged particles, such as alpha particles, have a greater probability of 
causing direct damage compared to X-rays, which cause more damage by indirect 
effects. The chemically reactive species produced by IR in the water react within 2-3 
nm from their site of origin with DNA and when they occur in clusters at the ends of 
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electron tracks, they generate locally multiply damaged sites (LMDS). LMDS 
comprise diverse forms of damage including single strand breaks (SSBs) and base 
damages that can combine to form DSBs (4). In this way, exposure to IR generates a 
spectrum of DNA damages, among which the most genotoxic lesions are DSBs. With 
increasing LET, LMDS are produced with higher probability. This does not imply that 
the absolute DSB yield would increase, because the energy deposited per LMDS 
also increases relative to low LET damage.  
2.2  Consequences of DSBs in eukaryotes 
IR does not cause instantaneous cell demise, but compromises instead further cell 
proliferation by generating DNA damage causing chromosomal aberrations and by 
inducing genomic instability. The genomic instability is one of the most important 
causes of carcinogenesis (5,6). DSBs generate chromosome fragments, which can 
miss-rejoin and generate problems in genome organization and in DNA sequence. 
These processes can cause shuffling of important genes. DSBs differ from other 
types of DNA lesions, in the sense that both strands of double helix are damaged, 
which prevents the use of the complementary DNA strand as a template for repair. 
As a result, DSB repair has to use alternative mechanisms to maintain the sequence 
of the DNA, and when these mechanisms fail chromosomal aberrations are 
generated. Common chromosomal aberrations include the loss or gain of whole 
chromosomes or chromosome fragments. Loss of large regions of a chromosome 
can inactivate tumour suppressor genes, while amplification of chromosomal regions 
may promote tumorigenesis by the activation of proto-oncogenes (7). When 
chromosome arms are exchanged, the aberration formed is known as a 
translocation, which can be either balanced or unbalanced and be associated with 
the deregulation of gene expression at the generated junctions (8). 
2.2.1 DSBs and chromosomal aberrations 
It is widely accepted that DSBs are involved in the formation of chromosome breaks. 
Thus, is has been reported that DSBs induced by restriction endonucleases cause 
chromosomal aberrations (9,10). 
There are two prevalent theories of chromosome aberration formation. The first 
theory is known as breakage and reunion (B&R) theory proposed by Lea and Sax in 
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1946. According to this theory a primary break is a complete severance of the 
chromatid “backbone” or “Chromonema”, leaving open break-ends capable of 
restituting (reforming the original sequence), illegitimate rejoining (fusing pair wise 
with foreign ends to form structural exchanges), or remaining open to appear at 
metaphase as “breaks” (terminal deletions). It is implicit in the B&R theory that 
“breaks” visible at metaphase are the residues of primary breaks that have neither 
restituted nor rejoined, i.e. we are viewing the potential progenitors of exchange 
aberrations (11). The second theory is known as the exchange theory proposed by 
Revell (1959 and 1963), according to which, all visible breaks are discontinuities, and 
therefore these visible breaks are the result of structurally incomplete intra-arm 
intrachanges, from those that are simply the result of failed restitution or rejoining of 
primary breaks (12).  
It is known to be a consistent and general phenomenon observed for normal cells 
with intact DNA repair mechanisms that cells exposed to IR in G1 or G0 arrive in their 
first mitosis with aberrations are virtually all of the chromosome-type, while after 
irradiation in S or G2, aberration are virtually all of the chromatid-type. While some 
cells irradiated in early S-phase may occasionally contain both chromosome-type 
and chromatid-type aberrations in the same cell, mostly chromatid-types are seen for 
irradiation at this time. It is also of considerable interest that the rule of “chromosome-
type aberrations” after G1 or G0 irradiation, and of “chromatid-type” after S or G2 
irradiation applies only for IR or agents known to produce prompt DSBs, such as 
neocarzinostatin, Bleomycins etc (13).  
In contrast to IR, DNA damaging agents that do not produce prompt DSBs also do 
not produce chromosome-type aberrations in the first mitosis after treatment in G1 or 
G0, but instead, produce chromatid-type aberrations (14). Chromatid-type 
aberrations can of course become derived chromosome-type if the cells bearing 
them survive into the second or later generations. The cell’s survival, when it bears a 
chromosome-type aberration will largely depend on whether the aberration is a 
symmetrical inter-change, i.e. an inversion or balanced translocation, which is not 
lethal, or its asymmetrical counterpart, i.e. an acentric or a centric ring or a dicentric 
with its acentric fragment, which is generally lethal. The latter form of chromosome 
aberrations are nearly always lethal for a normal diploid cell because of the large 
genetic loss associated with the acentric fragment loss in the cell progeny (15,16). 
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Thus, whether the aberration that is induced appears as a chromosome or chromatid 
type in the first mitosis, cells that carry them will generally die. Cells that survive with 
aberrations that are not lethal have also the potential to produce genomic changes of 
the type seen in malignancies. Chromatid exchanges occur at a much lower 
frequency than breaks. Exchanges represent the miss-rejoining of at least two DSBs 
(17). 
2.2.2 DSBs can also be necessary intermediates in important processes 
DSBs can actually be beneficial for the cell when they occur in a controlled manner in 
the context of specialized events that require rearrangements in the genome. 
Controlled enzymatic induction of DSBs is observed during the development of the 
immune system and the generation of genetic diversity during meiosis (18-20). DSB 
formation plays a very important role during meiotic homologous recombination in 
lower as well as in higher eukaryotes (21). It is safe to assume that cellular DSB 
repair mechanisms maintain continuous activity to ensure that the occurrence and 
resealing of DSBs will leave the cell unharmed. Also, when DSBs are inflicted into 
the genome by damaging agents, such as IR or radiomimetic drugs, the threat to cell 
life is sufficiently serious to set in motion, within minutes, decisive DNA-damage 
response pathways.  
2.3  Mechanisms of DSB repair 
In higher eukaryotes IR induced DSB can in principle be repaired by homologous 
recombination repair (HRR) and non-homologous end-joining (NHEJ). These repair 
pathways are supported by a well regulated DNA damage response (DDR) signalling 
cascade that culminates with the activation of cell cycle checkpoints. These two DSB 
repair modes differ in their requirement for a homologous DNA template and in the 
fidelity of DSB repair. HRR ensures accurate DSB repair, while D-NHEJ is 
considered as error prone pathway. The relative contribution of these two DSB-repair 
pathways is likely to differ depending on the stage of the cell cycle (22). HRR is 
thought to be more efficient in the S and G2 phases of the cell cycle due to the 
availability of sister chromatids (23). Theoretically, HRR could occur in G1 as well, by 
using the homologous chromosomes as a template for repair, but such events are 
hampered by the highly-ordered chromatin structure and the clearly defined and well 
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separated in the nucleus of the territories of the homologous chromosomes, which 
makes such events very rare. The preferred use of a sister chromatid as a repair 
template probably reflects a proximity effect.  
In the absence of a sister chromatid, DSB repair in G1 phase could still efficiently 
occur through D-NHEJ. Micro-homology dependent alternative pathways are also 
reported, which are functional in the absence of D-NHEJ (24,25). It is very important 
that cells accurately repair DSBs, because failure to do so can lead to mutations or 
genome rearrangements, and indeed a single un-repaired DSB is sufficient to kill a 
cell (26,27). The following sections describe DDR signalling, checkpoint activation 
and the pathways of DSB repair in detail. 
2.3.1 DDR signalling and cell cycle checkpoints  
The recognition and repair of DSBs is a complex process that draws upon a 
multitude of proteins. This is not surprising since this is a lethal lesion if left un-
repaired, and a lesion that can contribute to genomic instability and the consequential 
risk of cancer and other pathologies. DSBs activate DDR signaling, which results in 
the activation of cell cycle checkpoint pathways that facilitate specific DNA-repair 
mechanisms in the different phases of the cell cycle. Checkpoint-arrested cells 
resume cell-cycle progression once damage has been repaired, whereas cells with 
un-repairable DNA lesions undergo checkpoint adaptation, permanent cell-cycle 
arrest, or apoptosis. DDR signaling collectively involves sensing of DNA damage, 
signal its presence and mediate the cell cycle responses. These processes are 
regulated by post–translational modifications such as phosphorylation, 
ubiquitinylation and acetylation.  
2.3.1.1  DNA damage sensing 
IR induced DSBs act as a signal, which is sensed by DDR signalling proteins. 
Replication protein A (RPA) and the MRN complex are hypothesized to act as 
sensors of DNA damage and to help activate the DNA-damage-response-
transducing kinases, e.g. ATM and ATR (28,29). RPA is the major ssDNA-binding 
protein and is essential for DNA replication, repair and recombination (30). MRE11 
protein binds both ssDNA (single stranded DNA) and dsDNA (double stranded DNA) 
in a sequence independent manner. The nuclease activity of MRE11 processes the 
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3’-ssDNA, a binding site for RPA (31). The RPA–ssDNA complex inhibits any further 
nuclease activity and initiates the recruitment of the repair machinery (32,33).  
MRE11 is an 81-kDa protein that has an amino-terminal nuclease domain and two 
DNA-binding motifs. The mutated MRE11 gene is responsible for Ataxia-
telangiectasia-like disorder (ATLD). The clinical features of ATLD are similar to those 
in patients with AT, with a progressive, but slower and later onset of cerebellar ataxia 
(34). 
2.3.1.2  DNA damage signalling 
ATM plays a central role in DSB signalling. ATM normally exists as an inactive dimer, 
which dissociates into active monomers after sensing DSBs induced by IR. During 
this process, ATM undergoes intermolecular phosphorylation on Ser1981, Ser367, 
and Ser1893 (35). ATM autophosphorylation at Ser1981 was shown to be necessary 
for both monomerization and binding to regions flanking DSBs (36). In addition to the 
phosphorylation process, dephosphorylation of ATM by several phosphatases i.e. 
PP2A is also involved in the regulation of ATM activity (37). In the presence of DSBs, 
ATM phosphorylates a variety of protein targets, and activates several signalling 
cascades. ATM induces cell cycle arrest at the G1/S, intra-S, and G2/M phases 
through the action of intermediates, like p53 and Chk2 (38). The active ATM 
phosphorylates the histone H2A variant H2AX at serine 139 (known as H2AX), a 
critical substrate of the DNA signalling machinery, in response to DSBs (39,40). 
H2AX phosphorylation occurs at megabase regions surrounding the DSBs within 
seconds of DNA damage, suggesting that H2AX phosphorylation may be a critical 
component in early DNA damage signal transduction (41). The activated ATM kinase 
phosphorylates a set of other substrates, e.g. NBS1, also known as nibrin, on serine 
34 (42), MRE11 (43), MDC1 at Ser-635 and Ser-645 (mediator of DNA damage 
checkpoint 1) (44), BRCA1 (45), SMC1 (structural maintenance of chromosome 1) on 
serines 957 and 966 (46), CHK2 [checkpoint kinase 2] (47), p53 on Ser-15 (48), RPA 
(49), FANCD2 (Fanconi anemia complementation group D2 isoform) on Ser-222 
(50), Artemis (51), and DNA-PKcs at Threonine-2609 (52).  
Phosphorylated H2AX forms foci at and near the sites of DSBs, colocalizing with 
ATM, MDC1, 53BP1, BRCA1, the MRN complex, and many other DNA damage 
signalling and repair proteins (53,54). The initial migration of factors to DSBs does 
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not require H2AX, but the subsequent association with chromatin regions distal to 
the break site is dependent on the phosphorylation marks on H2AX (55). Therefore, 
H2AX is suggested not to recruit but to retain proteins, including the MRN complex, 
53BP1, and BRCA1 at the sites of DNA damage (54).  
ATR, which is classified as a member of the same PIKK family as ATM, is also an 
important DDR signalling protein. It is involved in the initiation of HRR via Chk1, a 
substrate kinase of ATR. Chk1 facilitates HRR through RAD51 phosphorylation, 
which attenuates the interaction between RAD51 and BRCA2. The regulation of this 
interaction is required for the appropriate chromatin binding of RAD51 via Chk1 and 
Chk2 (56). This indicates the possibility of involvement of ATM in HRR regulation 
through the activation of the ATR-Chk1 pathway. The proteomic analysis of the 
components of DNA repair machinery revealed an extensive network of more than 
700 proteins; all of which are phosphorylated by ATM and ATR in response to DNA 
damage (57). One of the targets of ATM and ATR kinases is the MRN complex 
(MRE11/RAD50/NBS1), a highly conserved protein complex involved in DNA 
replication, DNA repair, telomere maintenance, and signalling to the cell cycle 
checkpoints (58). The MRN complex plays a critical role in the DNA damage sensing, 
signalling and repair mechanisms, as well as in the maintenance of chromosomal 
integrity. According to the classical view, ATM is activated by IR, while ATR is 
activated by UV light. ATR and ATM are therefore considered to be activated by 
separate signals and are specialized in their responses to DNA damage (59).  
Recently it is reported that ATM substrates involved in cell cycle checkpoint signalling 
can be phosphorylated independently by ATR (60). 
While ATM knockout cells are viable, ATR-/- and CHK1-/- both are lethal in 
mammalian cells, indicating that the ATR/Chk1 pathway plays an essential and ATM-
independent role in mammalian cells. The function of ATM has been extensively 
studied in cell lines derived from ataxia telangiectasia patients that lack expression of 
the ATM protein. The lack of comparable cell lines for ATR has impaired analysis of 
its specific activities. Overexpression of catalytically inactive versions of ATR 
indicates that it is required for checkpoint responses after treatment of cells with 
agents that cause various forms of DNA damage or block replication (61-64). 
 
Introduction 
 
11
2.3.1.3  Cell cycle checkpoints 
The outcome of damage induced DDR signalling is the activation of cell cycle 
checkpoints. The division of a cell is under the control of cell-cycle checkpoints in the 
G1, S, G2, and M phases, the activation of which leads to arrest of the normal 
division process (26). It is generally assumed that cell-cycle arrest is necessary to 
provide the cell with time to effectively repair the DNA lesion. In the case of DSBs, 
cell-cycle arrest is thought to be primarily mediated by members of the 
phosphatidylinositol 3-kinase-like kinase (PI3KK) family, which are activated upon the 
onset of DNA breakage (26,59,65). In human cells, the activation of at least two PIKK 
signalling kinases- the ataxia telangiectasia mutated (ATM) and ataxia telangiectasia 
related (ATR) proteins – leads to phosphorylation and activation of the central cell-
cycle regulators p53, Chk1 and Chk2, which in turn facilitate G1 and G2 arrest via 
down regulation of Cdk2/Cyclin E and Cdk2/Cyclin B1, respectively (26). When the 
cell division is halted through checkpoint activation, several sets of enzymes come 
into play to repair the damage.  
The activation of the G2 checkpoint delays mitotic entry in the presence of DNA 
damage. Because the spindle checkpoint at mitosis only responds to spindle 
damages or miss-attached chromosomes (66), the G2 checkpoint is the last chance 
for correcting genomic damage prior to cell division (67). This fact probably explains 
its importance in the overall checkpoint response. Proteins participating in the 
activation of the G2 checkpoint are highly conserved in eukaryotes (68). It is well 
documented that the ultimate target of the initiated G2 checkpoint signal transduction 
pathway is Cdc2 (Cdk1) (69,70). In G2, this cyclin dependent kinase (Cdk) is 
activated after binding to cyclin B1, by a phosphorylation at Threonine-161 and a 
dephosphorylation at Threonine-14/Tyrosine-15 (69). In this way Cdk1 is associated 
with cyclin B1 and forms the so called mitosis promotion factor (MPF). See Figure 2.2 
(page 12) for the schematic representation of the G2-checkpoint activation. 
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Figure 2.2: Role of ATM and ATR in checkpoint activation (left). Activation of G2-
checkpoint through phosphorylation of Cdc25c. It is shown that phosphorylated Cdc25c 
can not dephosphorylate the cyclinB1/Cdk1 complex. Thus entry into mitosis is inhibited 
(right). 
 
(Modified from http://www.ruf.rice.edu/~rur/issue1_files/renthal.html & http://www.dkfz.de/en/f045/index1.html) 
It has been shown that cells lacking ATM have a defective IR-induced G2 checkpoint 
(71-75). However, Ford et al. (1984) argued that this AT phenotype was an artefact 
of the selective elimination of a sub population of AT cells (i.e. those die in G2). 
Further reports (76,77) support the finding of an increased G2 block in AT using 
different AT cell types. Beamish and Lavin (1994) resolved these apparently 
contradictory responses by considering the stage of the cycle at which the AT cells 
are irradiated: irradiation in G1 and especially S phase results in significant delay in 
G2, while irradiation in G2 gives reduced delay into mitosis and the following S phase 
(78). It was also shown that abrogated G2-checkpoint in AT cells compromises the 
repair of chromosomal breaks (74). 
ATR is shown to be recruited to the sites of ss-DNA bound by RPA. This recruitment 
occurs by a mechanism that requires ATRIP (79,80). Activated ATR mediates 
phosphorylation of protein kinase Chk1, which promotes the activation of the G2-
checkpoint and the HRR pathway of DSB repair (81,82). ATR is essential for 
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embryonic development (83,84), but expression of doxycycline inducible kinase dead 
dominant-negative ATR prevents G2-checkpoint responses after exposure to UV and 
ionizing radiation (61). 
Caffeine, a non-specific inhibitor of ATM and ATR sensitizes AT cells to IR-induced 
killing, suggesting that the target of caffeine in AT cells might be ATR (85). In this 
paper, it is shown for the first time that the prolonged G2-accumulation in irradiated 
AT cells is regulated by the ATR/CHK1 pathway. The IR induced, prolonged G2 
accumulation in AT cells is abolished by blocking the ATR-CHK1 pathway, indicating 
that the over-activated ATR-CHK1 pathway is responsible for the prolonged G2 
accumulation in irradiated AT cells.  
The breast cancer associated gene BRCA1 is also shown to be needed for G2-DNA 
damage checkpoint control, as well for HRR mediated repair of DSB (86,87). 
2.3.2 Homologous recombination repair 
Rad51 dependent HRR is usually an error-free repair pathway dependent on 
homologous sister chromatid strand availability as a template, which restricts its 
activity to S and G2 phase of the cell cycle (23). Using an intact DNA molecule as 
template allows the accurate repair of DSBs. The basic HRR machinery and its 
regulation are remarkably conserved among eukaryotes (88). In higher eukaryotes, 
HRR is driven by the proteins of the Rad52 epistasis group, which includes Rad51, 
Rad52, the Rad51 paralogs; Xrcc2, Xrcc3, Rad51B, Rad51C, Rad51D, and 
Rad54/Rad54B (89). In human cells, the products of breast cancer susceptibility 
genes, BRCA1 and BRCA2 (FANCD1), are also involved in HRR (90).  
The process of HRR is relatively slow but provides accurate repair of damaged DNA 
regions. It involves the following distinct steps (1) processing of DNA ends, (2) 
search for homology, strand invasion and formation of Holiday junction, (3) DNA 
synthesis, branch migration, and (4) final resolution of Holiday junction intermediates 
(see Figure 2.3, page 16). The initial cellular response to DSBs is mediated by ATM 
and one of the subunits of MRN complex Nbs1. The MRN complex is involved in 
primary DNA-end recognition and nucleolytic processing of the broken DNA ends into 
3’-end single-stranded DNA tails. CtIP [CTBP (C-terminus-binding protein of 
adenovirus E1A)-Interacting protein] is ubiquitinilated by BRCA1, thus is recruited to 
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DSBs together with MRE11, promotes DSB ends resection and results in the 
formation of recombinogenic 3’-overhangs (91,92). CtIP interacts with the MRN 
complex and enhances MRE11’s ssDNA dependent endonuclease activity. Although 
Mre11 and CtIP promote DNA end resection in the initial step of HRR, these two 
enzymes do not exhibit processive nuclease activity, which suggests for the 
existence of at least one more nuclease involved in this step. Bolderson et al. have 
shown the critical requirement of Exonuclease1 (Exo1) for resection of DSBs 
repaired via HRR (93).  The resulted 3’-overhangs, formed after the end resection 
step are rapidly bound by the ssDNA-binding protein RPA (replication protein A), 
which in general prevents the formation of secondary structures in the DNA, thus 
facilitating the formation of Rad51 nucleoprotein filament. Once resection is 
progressing, the ssDNA serve as a substrate for HRR but also leads to ATR 
activation that might also act to promote HRR. Consistent with this idea, ChK1 has 
been shown to facilitate HRR, at least in part by mediating phosphorylation of the key 
HRR protein, RAD51 (82). The DNA strand invasion and homology search steps of 
HRR require formation of a Rad51 nucleoprotein filament composed of thousands of 
Rad51 monomers bound to ssDNA. The formation of Rad51 nucleoprotein is also 
facilitated by the Rad51 paralogs; Rad51B, Rad51C, Rad51D, Xrcc2 and Xrcc3. 
Since RPA binds more avidly to ssDNA than Rad51, additional activities are required 
to load Rad51 on to RPA-coated ssDNA and to displace RPA. In mammalian cells, a 
critical mediator complex appears to include BRCA1/BARD1 and BRCA2 (FANCD1), 
probably bridged by the FANCN/PALB2 (partner and localizer of BRCA2) (94,95). 
BRCA2 is involved in the direct loading of Rad51 (96). The Rad51 nucleoprotein 
filament then captures duplex DNA and searches for homology. Studies using 
bacterial RecA indicate that the homology search probably occurs by way of random 
collisions between the nucleoprotein filament and the duplex DNA, thereby testing 
segments of the dsDNA in an interactive fashion until homology is found. Following 
synapsis, the invading strand sets up a D-loop intermediate, whereby the 3’-end 
primes DNA synthesis using the duplex DNA as a template. It is presently unclear 
which polymerase (s) mediate D-loop extension in vivo, but Pol η (DNA polymerase 
η) can perform this function in vitro (97). If the D-loop captures the second end of the 
break, the HJs (Holliday junctions) are formed which could yield upon appropriate 
resolution crossover or non-crossover products. However crossing over is rare during 
somatic HRR (23,98,99). The later steps of the process include polymerization of 
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nucleotides to restore degraded DNA strand and resolution of the recombination 
intermediates. The heterodimeric Mus81-Eme1 structure-specific endonuclease 
plays a role in the cleavage of D-loops, 3’ flap structures, nicked HJs and aberrant 
replication forks, suggesting its roles both upstream and downstream of HRR (100). 
Nagaraju and co-workers has shown that Rad51 paralogs Xrcc2 and Xrcc3 control 
the termination of gene conversion between sister chromatids (101). 
The Rad51 paralogs Rad51B, Xrcc2 and Xrcc3 are involved in HRR and the 
maintenance of chromosomal stability. DT40 cells deficient in RAD51 paralogs 
showed reduced levels of HR and a high percentage of cells have chromosomal 
aberrations (102). Murine cells deficient in XRCC2 or XRCC3 gene show low levels 
of HRR (23,103) and high levels of chromosomal aberrations and/or chromosomal 
miss-segregation at mitosis (104,105). It is important to consider that null mutations 
in core HRR genes such as RAD51, BRCA1 and BRCA2 are lethal in dividing cells, 
whereas null mutations in the Rad51 paralogs are embryonic lethal but not cell lethal 
(106).  
Several DDR signalling proteins are implicated in the regulation of HRR after 
induction of DSBs. I-SceI induced HRR was shown to be reduced several-fold in 
H2AX-/- cells (107). ATR has shown to affect HRR but not NHEJ (108). While ATM 
has been shown to promote HRR following IR induced DSBs (109), ATM deficiency 
did not reduce the HRR repair frequency of an I-SceI induced DSB (110). MRN 
generally promotes HRR rather than direct rejoining repair (NHEJ), and this may 
suggest how MRN could suppress tumorigenesis through the prevention of mutations 
in genomic DNA. Although ATM phosphorylates many factors involved in the HRR 
pathway such as BRCA1, Nbs1 and H2AX (57), the role of ATM in HRR regulation is 
still unclear (111). 
Adimoolam et al. (2007) showed that PCI-24781, an HDAC inhibitor inhibits HRR via 
down-regulation of Rad51 in Chinese hamster and human cells (112).  
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                                                                                                                [From IJima et al., 2008, (111)] 
 
 
D-NHEJ HRR 
Figure 2.3: Pathways of DSB repair in mammalian cells. D-NHEJ (left) and HRR (right) 
2.3.3 DNA-PK dependent non-homologous end-joining (D-NHEJ) 
In contrast to HRR, D-NHEJ requires little or no homology to repair DSBs. This 
pathway is not only used to repair DSBs generated by exogenous DNA-damaging 
agents, such as IR, but is also required to process the DSB intermediates generated 
during V(D)J recombination (113). NHEJ can lead to the loss of nucleotides, 
chromosomal translocations or chromosome fusions. The important proteins involved 
in D-NHEJ are the KU heterodimer consisting of the Ku70 and Ku80 subunits, 
catalytic subunit of DNA-PK, DNA-PKcs, Artemis and the complex between Ligase4 
(Lig4) and XRCC4 (see Figure 2.3, page 16). Ku heterodimer has a high affinity for 
DNA ends, which indicates its early role in the NHEJ process.  
After induction of DSBs, the Ku70/80 dimer binds to both broken ends of DNA within 
seconds (114). This DNA-Ku complex recruits the catalytic subunit of DNA-PK (DNA-
PKcs). The recruitment of DNA-PKcs to the broken ends increase its kinase activity 
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almost 10 folds. Once bound to the DNA ends DNAP-Kcs subsequently 
phosphorylates several cellular target proteins, including p53, the KU polypeptides 
and itself. In general, IR does not produce clean ligatable DNA ends, but often the 
ligation step is directly impossible due to the generation of altered nucleotides. 
Several enzymes including nucleases (Artemis) and polymerases (pol µ and pol ) 
are thought to be involved in the processing of single-stranded overhangs before 
ligation. A complex that consists of DNA, Lig4 and XRCC4 (X-ray-repair-cross-
complementing defective repair in Chinese hamster mutant 4) accomplishes the final 
ligation step. The activity of Lig4/XRCC4 complex is thought to be enhanced by the 
newly discovered protein XLF/Cernunnos (115).  
Both Ku70/80 subunits and DNA-PKcs are essential for repair by NHEJ, although 
defects in DNA-PKcs generally confer a milder phenotype than defects in Ku. DNA-
PK activity is undetectable in Ku-defective cell lines, indicating that DNA binding by 
the Ku70/80 heterodimer is essential for its activation (113). ATM functions in the 
NHEJ pathway through the phosphorylation of Artemis and DNA-PKcs (52,116). 
These results strengthen the importance of ATM in NHEJ. ATM is also shown to be 
important for V(D)J recombination (117). Moreover, there is a strong correlation 
between the protein level of DNA-PKcs and ATM. Results with knockdown of DNA-
PKcs using siRNA show that the level of ATM is also decreased proportionally to the 
efficiency of DNA-PKcs knockdown. 
It is still unclear to what extent the D-NHEJ pathway contributes to the inaccurate 
repair of DNA DSBs. After the generation of a DSB by RAG1/2, NHEJ proteins in the 
V(D)J recombination “inaccurately” join the DNA ends to generate diversity (118). 
One of the reasons why NHEJ is thought to be error prone relates to the chemical 
structure of radiation induced DNA ends that precludes end joining from being an 
accurate repair mechanism. This is further exaggerated by the fact that NHEJ is non-
templated repair mechanism, and thus conceptually unable to restore sequence at 
the damage site. Indeed, the majority of IR induced DSBs have non-ligatable ends 
and must be subjected to additional processing by a nuclease or polymerase to 
enable the subsequent ligation reaction. This end processing could result in a loss of 
several bases adjacent to the break point but also to the addition of new untemplated 
nucleotides. Mutants with defects in core D-NHEJ proteins remove a large proportion 
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of DSBs from their genome, utilizing an alternative pathway of NHEJ that operates as 
a backup pathway [B-NHEJ] (119) that is described next. 
2.3.4 DNA-PK independent non-homologous end-joining (B-NHEJ) 
Cells with mutations in components of D-NHEJ are still capable of repairing the 
majority of the IR-induced DSBs utilizing an alternative process, which, surprisingly, 
is not sensitive to mutations in HRR genes (120,121). This pathway is a distinct form 
of end-joining, normally suppressed by D-NHEJ, but which can be used as a backup 
when D-NHEJ is inactivated hence, B-NHEJ. B-NHEJ is likely to be an evolutionarily 
older pathway with less optimized synapsis mechanisms that rejoins DNA ends with 
slower kinetics and with half-times of 2-10 h. The slow kinetics and sub-optimal 
synapsis mechanisms of B-NHEJ allow more time for exchanges through the joining 
of incorrect ends and cause the formation of chromosome aberrations in wild type 
and D-NHEJ mutant cells. Within the D-NHEJ repair process, DNA ends are quickly 
captured by Ku cooperating with DNA-PKcs (see section 2.3.3) and are directed to 
D-NHEJ for rapid joining, kinetically suppressing the slower backup pathway of B-
NHEJ. Alternative pathways of end-joining such as B-NHEJ are expected to 
contribute significantly to the overall repair of DSBs when components of D-NHEJ 
are either absent from the vicinity of the break, or genetically/chemically 
compromised, and may therefore contribute to genome maintenance and stability 
(122).  
Despite the potential consequences of B-NHEJ function, little is known about the 
underlying mechanism, its regulation, as well as its integration into the cellular DSB-
processing apparatus. However, DNA LigIII is implicated in the B-NHEJ and the 
repair module PARP-1/XRCC1/DNA-LigIII that is involved in the repair of single 
strand breaks (SSB), also contributes to B-NHEJ (123,124). Interestingly, recent 
work identifies histone H1 as an additional factor contributing to DSB repair as a 
component of B-NHEJ (125).  
2.4  Chromatin remodelling and DSB repair 
The primary function of chromatin is to compress and compact genomic DNA, to 
protect it from nucleases and to organize genomic DNA into functional 
compartments. If such a condensed chromatin structure is stably maintained, DNA 
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metabolic events, such as transcription, replication and DNA repair, may not occur in 
a proper manner because of the limited accessibility of any enzymatic factors to 
DNA. The highly ordered structure of eukaryotic chromatin must be appropriately 
altered to permit access of repair factors to DNA. These alterations are termed 
chromatin remodelling and are executed by specific remodelling complexes in 
conjunction with histone modifications. During chromatin remodelling reactions, 
histones are altered by acquiring post-translational modifications and recruit proteins 
which can produce conformational changes in chromatin. Chromatin remodelling is  
achieved through the modification of DNA-histone interactions, removal of histones 
from DNA, exchanges of pre-existing histones with new histones, and by regulating 
the local density of histones by sliding them along the nucleosomes (126). Post 
translational modifications, such as methylation, acetylation, phosphorylation and 
ubiquitination alter or mark histones to make them available for the subsequent 
chromatin remodelling reactions. Therefore, these histone modifications are thought 
to function as a histone code (127). INO80, RSC, SWI/SNF and the SWR complex 
are some known chromatin remodellers in yeast. Because deficiencies in chromatin 
remodelling factors result in hypersensitivity to genotoxic agents, chromatin 
remodelling is considered necessary for the NHEJ and HRR (126,128). 
Studies show functional interactions between the chromatin remodelling process and 
the ATM/MRN complex (36,129-131). These works suggest that ATM and NBS1 are 
especially critical proteins, which operate during DSB repair through chromatin 
remodelling. It was found that proteins involved in the HRR pathway are often 
ubiquitinated and this seems to be essential for HRR.  The loss of Ubc13 reduces 
focus formation of RPA, BRCA1 and Rad51, but not that of H2AX, or 
autophosphorylated ATM. These results suggest that Ubc13 is required for the 
formation of a single-stranded overhang that is essential for the assembly of Rad51 
at DSB ends (132). The ubiquitin-proteasome system plays a critical role in HRR-
mediated DSB repair (133). Heterochromatic DSBs are generally repaired slowly 
than euchromatic DSBs, and ATM signalling is specifically required for DSB repair 
within heterochromatin. About 15% of DSBs require ATM signalling for their repair 
(134). 
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2.5  DSB repair pathway selection in different cell cycle phases 
The selection of pathway for DSB repair is a major issue in the field. Very little is 
known in general about the way cells chose between HRR and NHEJ. Is there simply 
a direct competition between the Ku heterodimer, Rad50/Mre11, or members of the 
hRad52 pathway in which the winner determines the course of repair? Or there are 
more subtle means of signalling which help the cell chose the appropriate repair 
pathway? It would make sense if repair by HRR was activated in late S or G2 phases 
of the cell cycle when a homologous copy is present in the form of a sister chromatid. 
How might this be achieved? Is this one of the functions of cell cycle replication forks, 
or of key members of the hRad52 pathway? Detailed investigation of the signalling 
events which accompany the formation of DSBs in mammalian DNA is a clear priority 
(113).  
Esashi et al. described cell cycle-regulated phosphorylation of BRCA2 that disrupts 
its interaction with RAD51. This posttranslational modification limits the function of 
RAD51 and thus HRR in S and G2 (135). It was shown that the phosphorylation of 
ABCDE and PQR clusters of DNA-PKcs are important determinants of pathway 
selection in different phases of the cell cycle. The phosphorylated PQR inhibits HRR 
while inhibition of its phosphorylation promotes HRR (136). Recently it was shown 
that HRR is increased in kinase dead DNA-PKcs mutants in comparison of null 
mutant. This phosphorylation related HRR selection is shown to be coordinated with 
ATM (137). BRCA1 is shown to be required for retention of RPA at the sites of DSBs 
and the cell cycle-dependent complex formation of BRCA1, CtIP, and MRN 
contributes to the activation of HR-mediated DSB repair in the S and G2 phases of 
the cell cycle (87). 
In G0 and G1 phase, DSBs are not extensively resected; allowing ATM activation 
and DSB repair by HRR is largely suppressed. In contrast, in S/G2 phase cells, 
DSBs are resected, thereby allowing ATR activation and HRR. Notably, this resection 
and events based on the ensuing ssDNA production take place effectively only after 
ATM activation has occurred and require the activities of MRN and CtIP. In S/G2 
phase, resection provides the ssDNA substrate for HRR and also leads to ATR 
activation that, among other things, also promotes HRR. Consistent with this idea, 
CHK1 has been shown to facilitate HRR, at least in part by mediating 
Introduction 
 
21
phosphorylation of the key HRR protein, Rad51 (82). NHEJ and HRR are not 
necessarily independent, since the coordinated action of both pathways is invoked by 
the cell in order to repair a DSB with minimal error (138). Studies in hamster cells 
suggested that when NHEJ is impaired, HRR seems to increase and vice versa 
(139,140). Cells obtained from DNA-PKCs deficient SCID mice that are impaired in 
NHEJ and V(D)J recombination show normal and even compensatory levels of HRR 
(141).  
It has been demonstrated that HRR using homologous chromosomes does not 
operate in mammalian cells for repair of DSBs by employing two model systems, 
namely lymphocytes from Down’s syndrome patients with three copies of 
chromosome 21 and Chinese hamster cells carrying one or two copies of human 
chromosome 8 (142,143). 
CtIP is required not only for repair of DSBs by homologous recombination in S/G2 
phase but also for microhomology-mediated end joining (MMEJ) in G1. The function 
of CtIP in HRR, but not MMEJ, is dependent on the phosphorylation of serine residue 
327 and recruitment of BRCA1 (92). The data in this paper support a model in which 
phosphorylation of Serine 327 of CtIP, as cells enter S phase, and the recruitment of 
BRCA1 functions as a molecular switch to shift the balance of DSB repair from error-
prone DNA end-joining to error-free homologous recombination.  
NHEJ substrates are double-stranded ends that have undergone limited processing, 
whereas HRR substrates are 3’ single-stranded tails produced by extensive 5’-end 
resection. This 5’-end resection is irreversible, at least in yeast, which makes it a 
good mechanistic stage for the repair pathway choice that channels DSB repair to 
HRR. DSB-end resection has been demonstrated to be tightly regulated through the 
cell cycle (144). In mammalian cells, the role of HRR in repair of DSBs is not evident 
unless the primary repair pathway, NHEJ is non-functional. Mitomycin-C resistance in 
DNA-PK null cells compared with WT cells suggests that the HRR pathway may be 
more efficient in cross-link repair in the absence of NHEJ. The incorrectly repaired 
chromatid damage observed in double-mutant cells may result from failed 
recombination or another error-prone repair process that is apparent in the absence 
of the two primary repair pathways (141). 
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2.6  Repair deficiency, genomic instability and cancer 
predisposition 
Enhanced sensitivity to IR in repair deficient cells was first shown in the mid-1970s 
and has been found to be a consistent feature of cells from all AT individuals tested 
(145). Deficient repair of DSBs, resulting in an abnormally high frequency of 
chromatid breaks after G2 exposure of cells to radiation, appears to be associated 
with cancer predisposition. Un-repaired DSBs contribute to genomic instability. Un-
repaired chromatid breaks representing DSBs can result in the chromosome 
deletions, translocations and gene amplifications seen in human cancers. This 
cytogenetic response of cells to radiation may be useful as a marker of cancer 
susceptibility and in identifying individuals at risk of developing cancer in cancer 
families (146). 
The mechanisms controlling G2 radiosensitivity are not yet fully understood (147). It 
is generally suggested that this sensitivity is determined by HRR, since this process 
is known to be involved in DSB repair, when cells are in the G2-phase (146). There is 
a need to understand the relationship between chromatid break frequency and 
cancer susceptibility, and to identify the genes of low penetrance that control these 
processes (148). The elevated chromatid radiosensitivity of breast cancer cases is 
indicative of the presence of low penetrance cancer-predisposing genes (149). It has 
been proposed that failure to repair a DSB, or its illegitimate repair, may contribute to 
a cell’s progression towards malignancy (150). Defects in HRR cause genomic 
instability. When the instability leads to aberrant expression or regulation of tumor 
suppressors or oncogenes, cell transformation and cancer may ensue (88). Clues 
that implicate HRR in the maintenance of genomic stability and in the prevention of 
carcinogenesis have come from cells and animals that are deficient in the BRCA1 
and BRCA2 genes. A striking connection between HRR and tumorigenesis has been 
suggested by the observation that the gene products disrupted in these hereditary 
breast cancer genes interact with the Rad51 protein. The interaction between BRCA2 
and Rad51 was found to be direct, while BRCA1 interacts indirectly with Rad51 
probably through BRCA2 (151,152). The demonstration that BRCA1-deficient mouse 
cells are impaired for the repair of chromosomal DSBs by HRR (153), provides 
evidence that loss of this DNA repair pathway promotes tumorigenesis. Recently the 
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Rad51 paralog, Rad51C, was shown to be a human cancer susceptibility gene 
associated with germline mutations in breast and ovarian cancer pedigrees (154).  
Fanconi anemia (FA) is a rare hereditary disorder characterized by progressive bone 
marrow failure, compromised genomic stability and increased incidence of cancer 
(155). However the roles played by the 13 different FA proteins identified till now is 
largely unknown, except for the case of FANCD1/BRCA2, which regulates the central 
HRR protein Rad51 (156). Yamamoto et al. reported that FA pathway is required for 
normal HRR repair (157,158). Recently the biallelic germline mutation in HRR protein 
Rad51C is shown to be associated with a FA-like syndrome (159). 
2.7  Relative roles of repair pathways in DSB repair 
The relative contribution of HRR and NHEJ in IR induced DSB repair is controversial 
in higher eukaryotes (160). Genetic models deficient in important factors of either 
pathway show increased radiosensitivity (161). The radiosensitivity of HRR deficient 
cells is mainly found in the late-S/G2 phase of the cell cycle  (22,162). The disruption 
of Rad52 confers no sensitization in mammalian cells (163,164). Inactivation of 
Rad54 causes a modest increase in radiosensitivity that is mainly associated with the 
late S/G2 phase (165). The disruption of Rad51 is lethal (166), but mutations in the 
Rad51 paralogs XRCC2 and XRCC3 confer significant radio-sensitivity (167,168). 
The relatively high radio-resistance of NHEJ-defective mutants in the late S/G2 
portion of the cell cycle further suggests that HRR promotes survival when sister 
chromatids are present (169,170). The DNA-PKcs and Ku80 deficient cells also 
showed increased radio-sensitivity (171,172). These results clearly implicate the 
importance of both D-NHEJ and HRR at the cell survival level.  
On the other hand, the results of DSB-rejoining by pulsed-field gel electrophoresis 
(PFGE) show that while D-NHEJ is the main repair pathway in mammalian cells, 
HRR deficient cells show no DSB repair defect even in the G2 phase of the cell 
cycle. In the absence of D-NHEJ, HRR does not seem to play a detectable role in 
DSB repair; rather B-NHEJ appears to repair DSBs in these cells with slower 
kinetics, and its function is shown to be enhanced in the G2-phase of the cell cycle 
(173-175). 
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Much of our understanding of mammalian HRR is derived from a system that utilizes 
the rare cutting endonuclease I-SceI to generate a site-specific DSB (176). The I-
SceI system clearly demonstrates that site directed chromosomal DSBs are potent 
inducers of HRR (177,178). I-SceI induced DSBs are useful for identifying proteins 
that influence HRR efficiency and/or outcome, but they do not fully mimic IR-induced 
DSBs which must be processed to produce ligatable/extendable ends, nor other 
damage produced by IR including single-strand breaks, base damage, and complex 
lesions. In mammalian cells, approximately 30-50% of I-SceI endonuclease induced 
site directed chromosome breaks have shown to be repaired by homologous 
recombination, while the rest is repaired by NHEJ (177).  
Golding et al. has reported that ATM is an important regulator of HRR and suggests 
that the effect of caffeine on HRR is primarily attributable to the inhibition of ATM, 
rather than ATR or any other PI3KK. They concluded that HRR is important for DSB 
repair in glioma cells with overall contribution to repair between 2 and 30% with the 
remaining repair carried out primarily by NHEJ. Also ATM specifically regulates HRR, 
whereas NHEJ is not influenced by ATM manipulation (179). Evans et al. has shown 
that HRR plays a very important role in the repair of Tirapazamine induced DSBs in 
human and hamster cells (180). Riballo et al. showed that ATM along with Artemis is 
required for repair of a sub-fraction of DSBs (about 10%) rejoining through alternative 
NHEJ, that requires Artemis nuclease activity, H2AX, 53BP1, Nbs1, Mre11, and 
DNA-PK (116).   
It is known that radiation induced cell killing results from the induction of 
chromosomal aberrations (CAs). DSBs are the primary lesions which give rise to 
chromosome aberrations (9,10). The chromosome changes we observe at 
metaphase are the end-product of a chain of events initiated by a molecular lesion in 
the DNA, particularly the DSB (181). Broken chromosomes are a serious threat to 
cell survival and their repair is necessary for the maintenance of genomic integrity. 
This repair of broken chromosomes is a challenge for dividing cells that need to 
distribute equally their genetic information to the daughter cells. Unresolved DSBs 
appear as chromosome breaks that can be efficiently scored in conventional 
metaphases or G2-premature chromosome condensation (G2-PCC). Evidence from 
genetically engineered mammalian cells containing an I-SceI DSB site shows that a 
single DSB in a cell’s genome is sufficient to cause a chromatid break (182). 
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It has been considered by some authors (146) that the disappearance of chromatid 
breaks with time after irradiation represents DSB rejoining (based on the breakage 
first model). 
What is the contribution of HRR in the processing of IR induced DNA DSBs and how 
can it affect the yield of chromosomal aberrations? The importance of HRR in the 
maintenance of genomic integrity is not questionable, but the exact mechanism of its 
involvement in protecting cells from IR induced chromosomal aberrations remains 
elusive (Bedford, JS, ISCA, 2009). The results of IR induced DSB repair obtained at 
different end-points like rejoining of DSB repair and cell survival point to a 
discrepancy regarding the contribution of HRR that requires elucidation. 
2.8  The goals of the present thesis 
The aim of the project is to study the relative contribution of D-NHEJ and HRR to the 
repair of G2-chromosomal breaks and to investigate the role of these repair 
pathways in IR induced G2-checkpoint signalling.  
The experiments are designed in such a way that DSB induction and repair are 
studied through their transformation to chromosome breaks that can be visualized by 
cytogenetic approaches in the G2 and M-phases of the cell cycle. The assay used 
allows the measurement of repair in a specific phase of the cell cycle without the 
need for synchronization and at very low radiation doses. This is not easily possible 
with other techniques such as PFGE, or the comet assay etc.  
The assay employed here is different from the classical “G2-assay” in terms of the 
post irradiation time interval chosen to collect the samples. In the “G2-assay”, 
chromosomal-radiosensitvity is evaluated at a fixed time point (146,147,183,184), 
while in this study kinetics of chromatid breaks is followed by collecting irradiated 
cells at hourly intervals for up-to 5 h post irradiation. This approach has been used in 
the past and the repair of chromatid breaks was shown to be connected with the 
repair of a subclass of DSBs (185,186). 
Appropriate Chinese hamster, mouse and human mutants/knockout cells are 
employed to study the role of D-NHEJ and HRR in the repair of chromatid breaks. 
Experiments are also carried out with cells deficient in important DDR signalling 
proteins to check the connection between DDR signalling and repair of chromatid 
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breaks. The results are confirmed by employing specific and non-specific inhibitors of 
DSB repair and DDR signalling proteins. 
The second important aspect of this thesis is to find the possible connection between 
HRR and G2-checkpoint signalling. Flow cytometric analysis is employed to study 
G2-checkpoint activation, maintenance and recovery in HRR and NHEJ deficient 
Chinese hamster and human cell lines. Histone H3 gets phosphorylated at serine-10 
early in mitosis and, therefore an antibody against phospho-histone H3 can be used 
to assess the IR-induced G2 checkpoint delay or entry into mitosis (187). Mitotic 
index (MI) variations are studied using this technique after exposure of cells to 1 Gy 
X-rays. These variations in mitotic index reflect the G2-checkpoint activation and 
subsequent recovery.  
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3.  Materials and Methods 
3.1  Cell lines 
Table 3.1 The cell lines used for the experiments are listed in the table below 
S/No  Species Cell line name  Cell type Mutation(m)/Knockout 
(KO) 
1 Chinese 
hamster 
CHO10B4  Ovarian Wild type 
2 Chinese 
hamster 
V79-S171  Fibroblast Wild type 
3 Chinese 
hamster 
Irs1SF Ovarian XRCC3 m 
4 Chinese 
hamster 
Irs1tor Fibroblast XRCC2 m 
5 Chinese 
hamster 
Irs1-clone1 Fibroblast Corrected for  XRCC2 
6 Chinese 
hamster 
Xrs5 Ovarian XRCC5 (Ku80) m 
7 Chinese 
hamster 
Irs20 Ovarian DNA-PKcs m 
8 Chinese 
hamster 
Irs20-K147E Ovarian Corrected for DNA-
PKcs 
9 Chinese 
hamster 
XR1 Ovarian XRCC4 m 
10 Chinese 
hamster 
Rad51D1 Ovarian Rad51D KO 
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11 Chinese 
hamster 
Irs1SF Clone X5-1 Ovarian Corrected for  XRCC3 
12 Chinese 
hamster 
Irs2 tor Fibroblast Rad51B m 
13 Chinese 
hamster 
Irs3 tor Fibroblast Rad51C m 
14 Chinese 
hamster 
V-C8 Fibroblast BRCA2 m 
15 Mouse MEF Ligase 4+/+ p53 -/- Mouse embryo fibroblasts Wild type 
16 Mouse MEF Ligase 4-/- p53 -/- Mouse embryo fibroblasts Ligase 4 KO 
17 Mouse MEF Ligase 4+/+ / RAD54-/- /  p53 -/- 
347E  Clone 1  
Mouse embryo fibroblasts Rad54KO 
18 Mouse MEF Ligase 4-/- / RAD54-/- /  p53 -/- 346B  Mouse embryo fibroblasts Ligase 4 and Rad54 double 
KO 
19 Mouse H2AX -/-, p53 -/- Fibroblasts H2AX KO 
20 Mouse H2AX +/+ p53 -/- (PW) Fibroblasts Control for H2AX KO 
21 Mouse 53BP1-/- ES Cells Embryonic stem cells 53BP1 KO 
22 Mouse 53BP1+/+ ES Cells Embryonic stem cells Control for 53BP1 KO 
23 Human M059K Glioma Control for M059J 
24 Human M059J Glioma DNA-PKcs m 
25 Human HCT116 wt Colorectal tumor Wild type 
26 Human HCT116 DNA-PKcs -/- Colorectal tumor DNA-PKcs KO 
27 Human HCT116 Ligase 4 -/- Colorectal tumor Ligase 4 KO 
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28 Human Capan-1,BHA Transfection Breast  Control for capan1 
29 Human Capan1 Pancreatic tumor BRCA2 m 
30 Human HCC4.10 (HCC1937 with wt 
BRCA1) 
Breast cancer Control for HCC4.12 
31 Human HCC4.12 (HCC1937 with 
empty vector) 
Breast cancer BRCA1 m 
32 Human Mrc5 SV1 Fibroblasts Wild type 
33 Human AT5BIVA Fibroblasts ATM m 
34 Human Nbs1LB Fibroblasts NBS1 m 
35 Human GM-847 Fibroblasts Control for GM847-
ATRkd 
36 Human GM-847ATRkd Fibroblasts ATR kinase dead 
(doxycycline induced) 
37 Chinese 
hamster 
V3 Ovarian DNA-PKcs m 
 
3.2  Cell culture and growth conditions 
All cells were incubated at 37°C in an atmosphere with 5% CO2 and 95% air (MCO-
18AIC, Sanyo CO2 incubator). CHO10B4 were grown in McCoy’s 5A medium 
supplemented with 5%FBS and all other hamster cells were grown in MEM 
supplemented with 10% FBS. Mouse embryo fibroblasts (MEF) were grown in DMEM 
medium supplemented with 10% FBS and antibiotics. Human HCT116 colorectal 
tumor cells were grown in McCoy’s 5A medium supplemented with 10% FBS and 
antibiotics. Breast cancer and pancreatic tumor cells were grown in RPMI medium 
supplemented with 15% FBS and antibiotics. Human glioma cells were maintained in 
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DMEM with 10% FBS. The rest of human fibroblast cells were grown in MEM 
medium supplemented with 10% FBS and antibiotics. 
3.3  Chemicals and inhibitors 
Colcemid (L-6221, Biochrome AG) was used at 0.1 µg/ml to accumulate metaphases 
(Stock: 10µg/ml in PBS w/o Ca++, Mg++). For G2-PCC induction, Calyculin A (C-3987, 
LC laboratories) was used at the concentration of 50-100nM (Stock: 10µM in DMSO). 
Calyculin A is a Serine/Threonine Phosphatase Inhibitor, which induces PCCs 
efficiently in interphase cells (188). Hypotonic solution was prepared by dissolving 
Potassium Chloride (Carl Roth GmbH & Co.) in Milli-Q water (Z00QSV001, Millipore, 
18.2 MΩ·cm at 25°C) to obtain 75mM working solution. Carnoy’s fixative was 
prepared by adding 3 parts methanol (Sigma Aldrich) and 1 part glacial acetic acid 
(Carl Roth GmbH & Co.). Hypotonic solution and Carnoy’s fixative were prepared 
fresh on the day of the experiment. Microscope slides, 76X26 mm (H-872, Roth 
Karlsruhe) were used for making cytogenetic preparations. 2.5 ml of ready to use 
Giemsa stain (Carl Roth GmbH & Co.) was diluted in 50 ml of Sorenson’s buffer 
(10582-013, Gibco, Invitrogen) to stain the slides. Slides were mounted using 24X60 
mm coverslips (H-878, Roth Karlsruhe). Entellan (Merck) was used as a mounting 
medium. Caffeine (C-8960 Sigma-Aldrich) was dissolved in Milli-Q water to prepare a 
200mM stock solution. The solution was sterilized by passing through a 0.22μm filter 
and stored at RT. 4mM caffeine was used as the working concentration. Low 
concentrations of caffeine are shown to inhibit the kinase activity of ATM kinase, and 
higher concentrations also inhibit ATR and DNA-PKcs (189). 2-morpholin-4-yl-6-
thianthren-1-yl-pyran-4-one (118500, Calbiochem, also known as KU-55933) was 
dissolved in DMSO (Dimethyl sulfoxide) (D8418, Sigma-Aldrich) to prepare a 10mM 
stock solution that was stored at -20 °C in the dark. 10 μM was used as the working 
concentration. KU-55933 is a highly specific small molecule ATP competitive inhibitor 
of ATM. It was identified via screening of a drug library based on LY294002, a non-
specific inhibitor of ATM (190). PCI-24781 (Mr 434) was obtained from 
Pharmacyclics. PCI-24781 (formerly CRA-024781) is a broad-spectrum phenyl 
hydroxamic acid HDAC inhibitor being evaluated in phase I clinical trials in patients 
with neoplastic disease. Adimoolam et al. (2007) have reported that PCI-24781 radio-
sensitizes the human and hamster cells by down-regulating Rad51 dependent HRR 
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(112). 2 μM and 0.5 μM PCI-24781 were used as the working concentrations. MIRIN 
is a specific inhibitor of the MRN complex. It inhibits MRN dependent ATM activation 
and abolishes the endonuclease activity of Mre11. The consequence of MIRIN-
dependent MRN inhibition is the prevention of G2/M checkpoint activation and HRR 
repair (191). MIRIN (6-(4-hydroxyphenyl)-2-thioxo-2, 3-dihydro-4 (1H) pyrimidinone) 
was synthesized by Specs Research laboratory, Delft, The Netherlands (ID No: AG-
690). 30, 50 and 100 μM MIRIN was used as the working concentration. PARP-1 
inhibitor PJ34 was obtained form Alexis Biochem. 10 μM was used as the working 
concentration 
3.4  Irradiation 
Irradiations were carried out with an X-ray machine (GE-Healthcare) operated at 320- 
kV, 10 mA with a 1.65 mm Al filter (effective photon energy approximately 90 kV), at 
a distance of 50 cm, and a dose rate of approximately 1.3 Gy/min. Dosimetry was 
performed with a PTW and/or a chemical dosimeter, which were used to calibrate an 
infield ionization monitor. An even irradiation was ensured by rotating the radiation 
table. Cells were returned to the incubator immediately after IR. 
3.5  Clonogenic survival assay 
Cell radiosensitivity to killing was determined by the clonogenic survival assay. 
Exponentially growing cells were irradiated with different doses, at room temperature 
and trypsinised immediately at 37°C. Cells were seeded into 60mm dishes, in 
duplicate, at various densities aiming at approximately 100 colonies/dish. After an 
incubation period of about 7 days, colonies were stained with crystal violet solution 
and colonies with more than approximately 50 cells were counted. Cell populations 
enriched in G1 and G2 phase cells were obtained by centrifugal elutriation and used 
to determine cell radiosensitivity to killing. 
3.6  Cytogenetic assays 
The experiments are designed in such a way that DSB induction and repair are 
studied through their transformation to chromosome breaks that can be visualized by 
cytogenetic approaches in the G2 and M-phases of the cell cycle. The assay allows 
measurement in specific phases of the cell cycle and at very low radiation doses, 
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which is not easily possible with other techniques of DSB repair such as PFGE, the 
comet assay etc.. 
3.6.1 Assay to measure the kinetics of G2-chromosome breaks at 
metaphase:  
Exponentially growing cell cultures were irradiated with 1 Gy X-rays. Following 
irradiation cells were allowed to repair for 1 to 5 h at 37°C to detect only the response 
of cells in G2 phase at the time of irradiation. Colcemid was added for 1 h aimed to 
block metaphases prior to harvesting the respective time point, except for the 1 h 
time point, where colcemid was added for 30 min before harvest to allow the 
migration of cells which were at the mitosis during irradiation. Cells were trypsinized, 
treated with hypotonic solution (75mM KCl) for 10 min at room temperature (RT) and 
fixed in Cornoy’s fixative (3X). The fixed cells were dropped on clean glass slide and 
stained with 3% Giemsa stain prepared in Sorenson’s buffer. For each experimental 
point about 300 cells were scored for chromatid damage from three independent 
experiments. Standard criteria were used for scoring. During scoring chromatid 
breaks and gaps were considered, the latter only when longer than the chromatid 
width. The chromosome exchanges were counted as two chromatid breaks. Bright 
field microscopy (Olympus VANOX-T, Japan) was employed to facilitate scoring. This 
protocol employed here is the modified protocol used by Bryant et al., 2008 (186). 
See appendix 4 and 5 (page 98-99) for the CHO and human metaphase spreads, 
showing chromatid breaks and chromatid exchanges. 
3.6.2 Premature chromosome condensation (PCCs) 
To study the influence of G2 checkpoint on chromosome break repair kinetics, 
exponentially growing cell cultures were irradiated with 1 or 2 Gy X-rays and allowed 
to repair at 37°C for 1 to 4 h after irradiation. 50 nM Calyculin-A was added for 45 
min before harvesting the respective time point to induce PCCs. This time for 
calyculin-A treatment is considered in the calculation of the repair time. Cells were 
harvested and prepared for cytogenetic analysis in the similar way as for 
metaphases. About 150 G2-PCCs were scored for each experimental point from 
three independent experiments. During scoring excess PCC fragments were 
considered. The chromosome exchanges were counted as two chromatid breaks. 
Materials and Methods 
 
33
Bright field microscopy (Olympus VANOX-T, Japan) was employed to facilitate 
scoring. 
3.7 Flow cytometry 
3.7.1 Cell cycle analysis by flow cytometry 
Propidium iodide (PI) binds to DNA proportional to its mass. Cell cycle distribution 
was assessed by measuring PI fluorescence on a flow cytometer. Cells were washed 
with cold PBS and trypsinized at 37°C for 5 min. Single cell suspensions were 
prepared in 5 ml cold fresh media. About 1 million cells were collected and 
centrifuged at 1500 RPM, 4°C for 5 min. The cell pellets were washed with cold PBS 
and fixed in 70% ethanol at -20°C overnight. Supernatant was removed by 
centrifugation at 1500 RPM for 5 min. Pellets were washed with cold PBS and 
incubated in PBS containing PI (40 μg/ml) (81845, Sigma-Aldrich) and RNase (62 
μg/ml) (R4875, Sigma-Aldrich) at 37°C for 30 min in the dark. Samples were 
measured on a flow cytometer (COULTER EPICS XL, BECKMAN COULTER) 
according to pre-established protocols, see Appendix 2 (page 96). 20,000 cells per 
sample were counted and the single cell population was gated to obtain standard 
histograms. Histogram files (*.HST) were generated by counting the frequency of 
cells with same PI signal intensity. 
The fractions of cells in the different phases of the cell cycle were calculated using 
the Wincycle® software. HST files were loaded into the Wincycle®. The parameter 
“S-phase growing order” was carefully chosen between 0.1 to 2, until the prediction 
model fitted the histogram shape. Cell cycle distributions were automatically 
calculated. G2 arrest kinetics was obtained by plotting the G2 fraction as a function of 
time after IR. 
3.7.2 Determination of mitotic index 
Bivariate flow cytometry was used to simultaneously measure DNA content and the 
levels of phosphorylated Histone-3 (H3-pS10). Briefly, 0.6-0.8 million cells were 
prepared as single cell suspension in cold fresh media after the completion of 
respective time point. After centrifugation at 1500 RPM, the cell pellets were washed 
with cold PBS and fixed in 70% ethanol at -20°C overnight. Supernatants were 
Materials and Methods 
 
34
removed by centrifugation at 1500 RPM for 5 min. Cells were further permeabilized in 
2 ml permeabilization solution (PBS + 0.25% Triton X-100) on ice for 15 min. 
Supernatants were removed by centrifugation at 1500 RPM and the pellets were 
washed with cold PBS. Cells were blocked in blocking buffer (PBS + 0.05% Tween-
20 + 1% BSA (8076.2, ROTH)) at RT for 45 min in the dark with gentle agitation. 
Primary antibody H3-pS10 rabbit polyclonal (06-570, Upstate) was diluted 1:150 in 
blocking buffer. After centrifugation at 1500 RPM for 5 min, the pellets were 
suspended in 100 μl diluted primary antibody and incubated for 2 h at RT in the dark 
with gentle agitation. The primary antibody was diluted in 5 ml PBS and the cells 
were washed 3 times with PBS. Secondary antibody Rabbit IgG-FITC (AP307F, 
Chemicon), was diluted in blocking buffer (1:200). Cell pellets were incubated with 
100 μl conjugated secondary antibody for 90 min at RT in the dark. Secondary 
antibody was removed by diluting in 5 ml PBS and washing with PBS three times. 
Cells were then incubated with PI plus RNase at 37°C for 30 min in the dark before 
measuring on a flow cytometer. A total 20,000 cells were measured. Proper gating 
was applied to detect H3-pS10 positive cells and to calculate their fraction in the total 
population. Compensation was applied when necessary. See appendix 3 (page 97) 
for the settings for bivariate flow cytometry. 
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4.  Results 
4.1  Clonogenic survival assay  
The clonogenic survival assay is a well accepted method for determining the 
radiosensitivity of different cell lines. We evaluated therefore selected CHO wild type, 
D-NHEJ and HRR mutants for radiosensitivity to killing. Results are summarised in 
Figure 4.1 (page 36). Both exponentially growing D-NHEJ (xrs5) and HRR (irs1SF) 
deficient cells show increased radiosensitivity compared to their wild type counterpart 
(Figure 4.1 A, page 36). Also HRR deficient irs1 cells showed significant 
radiosensitivity when compared to V79, the wild type parental cell line (Figure 4.1 B, 
page 36). These results confirm previous studies  (163,167) and show that both HRR 
and D-NHEJ protect cells of IR-induced cell killing. The above experiments were 
carried out with asynchronously growing cell populations that contain cells in all 
phases of the cell cycle. It is well established that the radiosensitivity of cell fluctuates 
considerably throughout the cell cycle, with cells at mitosis and early S being 
radiosensitive and cells in mid-G1 and mid-S radioresistant. When measuring 
intrinsic radiosensitivity using asynchronous cells, the result obtain will reflect the 
radiosensitivity of the most radioresistant subpopulation i.e. S-phase in the case of 
CHO cells (161). For a more in depth analysis of this parameter, we checked the 
radio-sensitivity of elutriated G1, S and G2 cells from CHO and irs1SF cells. No 
significant difference was observed between G1, S and G2 fractions in CHO cells 
(Figure 4.1 C, page 36), a result reflecting the suboptimal synchronization achieved. 
However, in S-phase populations of irs1SF cells a significant increase in 
radiosensitivity is observed compared to G1 and G2 cell populations (Figure 4.1 D, 
page 36), which is in line with earlier studies implicating HRR in the development of 
S-phase dependent radioresistance (192).  
4.2  The contribution of D-NHEJ and HRR in the repair of IR-induced 
G2-chromosome breaks 
As outlined in the introduction, DSBs are the principal lesions, responsible for IR 
induced cell killing, an effect that is mainly mediated through the induction of  
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Figure 4.1 Clonogenic survival assay in wild type, D-NHEJ and HRR deficient Chinese 
hamster cells. Exponentially growing asynchronous cultures, or synchronous cells enriched 
in G1, S and G2 phase of the cell cycle obtained by centrifugal elutriation, were irradiated 
with various doses of X-rays and allowed to form colonies. The surviving fraction is plotted 
as a function of radiation dose. (A) Exponentially growing wild type, D-NHEJ and HRR 
mutants of Chinese hamster ovary origin, (B) Exponentially growing wild type and HRR 
mutants of Chinese hamster fibroblast origin, (C) Elutriated CHO wild type cells, (D) 
Elutriated HRR deficient irs1SF cells. Histograms of elutriated fractions used for 
experiments are shown in the top part of (C) and (D). 
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chromosome aberrations. We wished to evaluate the contribution of D-NHEJ and 
HRR to the repair of DSBs through their transformation into G2-chromosomal breaks  
 (cytogenetically termed as chromatid breaks). The assay employed is described in 
the “Introduction” and under “Materials and Methods”. The kinetics of chromatid 
break rejoining in wild type, D-NHEJ and HRR deficient Chinese hamster mutants 
are summarized in Figure 4.2 (page 39). The wild type CHO10B4 and V79 cells show 
about four chromatid breaks/cell on average, after 1 h of 1 Gy X-rays; these breaks 
are repaired with time and ~ 0.5 chromatid breaks/cell (~10% of initial breaks) remain 
unrejoined 5 h post irradiation (Figure 4.2 B, E and G, page 39). This decrease in 
chromatid breaks follows first order kinetics and represents the repair of a subset of 
DSBs, which cause chromatid breaks. They represent 10-20% of the induced DSBs 
and is presently unknown why only a subset of DSBs causes direct chromatid 
breaks. The half repair time (T1/2) of the repair of chromatid breaks in wild type cells 
is ~ 2 h. In the following sections we compare the results of wild type CHO cells to 
those obtained with D-NHEJ and HRR deficient mutants. Please refer to Table 4.1 
(page 62) for a comparison of residual damage and repair half times between wild 
type cells and the different mutants. 
4.2.1 NHEJ deficiency does not affect the repair of chromosome breaks 
in the G2- phase of the cell cycle 
The D-NHEJ Chinese hamster mutants xrs5, irs20 and XR1 show increased levels of 
chromatid breaks (~ 2 - 2.5 fold above the WT), which are repaired with kinetics 
identical to that of wild type cells (Figure 4.2 B, C, D and G, page 39). The T1/2 for 
xrs5, irs20 and XR1 is about 2.5 h, 2 h and 3.3 h respectively and residual damage 
after 5 h is between 8 and 15% (Figure 4.2 H, page 39). These results indicate that 
fast repair is one of the reasons why relatively few DSBs lead to chromosome 
breaks.  The repair of these breaks seems to be unaffected by the D-NHEJ 
deficiency, at least for the cells that somehow manage to enter mitosis despite the 
activation of the G2 checkpoint. Our results with xrs5 cells confirm the results of 
earlier studies and validate our methods and approaches  (186,193).  
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4.2.2 Is HRR responsible for the repair of G2-chromosomal breaks?  
Since in D-NHEJ deficient cells HRR remains in principle functional, we measured 
the kinetics of chromatid break repair in HRR deficient CHO cells. We wished to 
examine whether HRR is responsible for the repair of chromatid breaks seen in D-
NHEJ deficient cells. HRR deficient irs1 and irs1SF cells show an elevated number of 
initial chromatid breaks (~1.5 times more than WT cells). Notably, the majority (~ 
80%) of these breaks remain un-rejoined (Figure 4.2 E, F, G and H, page 39). This is 
particularly striking vis-à-vis the observation that in HRR deficient cells D-NHEJ 
repairs practically all IR-induced DSBs, even at significantly higher doses of radiation 
and even for cells tested in the G2 phase of the cell cycle (174,175). Correction of 
irs1 cells through transfection of a functional XRCC2 gene (irs1 Clone1 cells) 
restores their capability to repair G2-chromosome breaks (Figure 4.2 E, page 39). 
These results identify HRR as the candidate repair pathway for chromosome breaks 
in the G2-phase of the cell cycle. We also confirm that D-NHEJ defects do not 
compromise the repair of chromatid breaks in cells escaping the G2 arrest. However, 
our results with irs1 cells do not support the results reported by Bryant P.E. et al., 
2008 (186), where it is claimed that irs1 cells repair G2-chromosome breaks with 
kinetics similar to the wild type. The reasons for this apparent discrepancy are 
presently unknown. 
4.2.3 Coupled HRR/NHEJ defects cause increase the initial level of 
chromatid damage and inhibit its repair 
The results with irs1 and irs1SF cells suggest a role for HRR in the repair of G2-
chromosome breaks. However, B-NHEJ can also contribute to the repair of 
chromatid breaks in G2 irradiated cells. This expectation is strengthened by the 
observation that B-NHEJ is more prominent in the G2-phase of the cell cycle 
(174,175). To explore this possibility we evaluated repair of G2-chromosome breaks 
in MEF-347B double knockout cells, which are deficient in Lig4 and Rad54 (proteins 
involved in D-NHEJ and HRR pathways of DSB repair, respectively). Wild type 
MEFs, LIG4-/- MEFs and Rad54-/- MEFs are used as controls in this experiment. 
Exponentially growing cells were irradiated with 1Gy X-rays and prepared for scoring 
chromatid breaks.  
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Figure 4.2 Kinetics of chromatid breaks in exponentially growing Chinese hamster cells, 
irradiated with 1 Gy X-rays and allowed to repair for up-to 5 h after irradiation. The number 
of chromatid breaks per cell is plotted against time. (A) Dose response curves for CHO 
cells, (B, C and D) repair kinetics in D-NHEJ deficient hamster cells, (E and F) HRR 
deficient hamster cells, (G) Comparison between initial and residual damage in different 
hamster mutants, (H) Comparison of % residual damage [% of initial breaks] in different 
hamster mutants. The data points represent mean and standard-deviation from 2 or 3 
independent experiments. 
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The results obtained in this experiment are summarized in Figure 4.3 (page 41). 
LIG4-/- MEFs show an ~2 fold increase in initial chromatid breaks, which are  
repaired in cells that escape the G2 arrest with kinetics similar to that of wild type 
cells - T1/2 ~ 3 h (Figure 4.3 A, F and G, page 41). Rad54-/- MEFs 346E show about 
same number of initial chromatid breaks as wild type cells but leave ~ 52% breaks 
un-rejoined at the 5 h time point; the T1/2 in this set is about 4.5 h (Figure 4.3 B, F and 
G, page 41). The double knockout LIG4-/-/Rad54-/- (347B) MEFs show an ~ 3 fold 
increase in initial chromatid breaks and leave their majority (~ 71%) un-rejoined at 
the 5 h time point (Figure 4.3 C, F and G, page 41). Another interesting observation 
in this experiment is that the frequency of chromatid exchanges increased ~ 5 fold in 
LIG4-/-/Rad54-/- (347B) MEFs double-knockout cells in comparison of WT cells 
(Figure 4.3 E, page 41). Chromatid exchanges (Figure 4.3 D, page 41, indicated by 
arrow-head) are chromosome miss-rejoining events. Please refer to Table 4.2 (page 
63) for a comparison of residual damage and half times of repair between wild type 
and mutant cells.  
The above results strengthen and support results obtained with HRR deficient CHO 
cells and suggest a role for HRR in the repair of G2-chormosomal breaks in rodent 
cells. The results with LIG4-/- MEFs also allow similar conclusions to those obtained 
with CHO D-NHEJ mutants. Rad54-/- MEFs do not show as a strong phenotype as 
the HRR deficient CHO mutants, both in terms of initial damage and the kinetics of 
rejoining of chromatid breaks. This difference is likely due to the less essential role of 
Rad54 in HRR as compared to XRCC2 and XRCC3. Indeed previous studies showed 
that disruption of Rad54 in the mouse confers a modest increase in radiosensitivity to 
killing (165), while XRCC2 and XRCC3 mutants display significant radiosensitivity 
(167,168).  
The many fold increase in chromatid exchanges in LIG4-/-/Rad54-/- MEFs, suggests 
that the error-prone alternative pathway, B-NHEJ, rejoins chromatid breaks in the 
absence of the two main repair pathways. However, the observation that chromatid 
break repair was practically completely inhibited in HRR mutants suggests that 
exchanges occurred between DSBs that are not normally transformed to 
chromosome breaks. Thus an increase of miss-rejoining events in the form of 
chromatid exchanges is observed when an error free pathway like HRR is  
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Figure 4.3 Kinetics of chromatid breaks and exchanges in exponentially growing MEFs 
irradiated with 1 Gy X-rays and allowed to repair for up-to 5 h after irradiation. Number of 
chromatid-breaks/cell is plotted against time. (A) LIG4-/- cells,  (B) Rad54-/- cells, (C) LIG4-/- 
Rad54-/- double knockout cells, (D) Metaphase spread; arrows represent chromatid breaks 
and arrow head represents chromatid exchange, (E) Kinetics of chromatid 
exchanges/100cells, (F) Comparison between initial and residual damage in different  MEF 
mutants, (G) Comparison of % residual damage (% of initial breaks) in different MEF 
mutants. 
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compromised. Pluth et al. in 2001 also observed incorrectly repaired chromatid 
damage in cells with defects in both D-NHEJ and HRR, which they attributed to failed  
homologous recombination or to the function of another error-prone repair process 
operating in the absence of the two primary repair pathways (141). Notably, LIG4-/- 
/Rad54-/- (347B) MEFs show no defect for IR induced DSB-rejoining over that 
observed in LIG4-/- MEFs, even when analyzed in the G2 phase of the cell cycle 
(174).  
4.2.4 Is HRR also important for the repair of G2-chromosomal breaks in 
human cells? 
The next important question was whether species specific variability exists for HRR 
mediated repair of G2-chromosome breaks? To address this question, we studied 
the kinetics of chromatid break repair in wild type, D-NHEJ and HRR mutant cells of 
human origin. Exponentially growing cells were irradiated with 1 Gy X-rays and 
prepared for analysis of chromatid break repair kinetics. The results obtained are 
summarized in Figure 4.4 (page 43). The wild type human cells show ~ 6 to 8 
chromatid breaks as initial damage, which is repaired with a T1/2 of 2 to 3 h in  cells 
from different origins (Figure 4.4 A, B, C and D, page 43). The residual damage in 
wild type cells from different origins ranges between ~ 2.5% to 20% (Figure 4.4 F, 
page 43). In LIG4-/- or DNA-PKcs-/- HCT116 colon cancer cells, an ~ 2 and 3 fold 
increase in the initial number of chromatid breaks is observed, respectively, as 
compared with wild type cells (Figure 4.4 A, page 43). The kinetics of chromatid 
breaks is identical to that of wild type cells and the majority of breaks are repaired 
within 5 h (residual damage of ~ 30% and T1/2 ~ 3.2 to 4 h). The DNA-PKcs mutant 
human glioma cells, M059J, show an ~ 2.5 fold increase in initial damage with the 
majority of breaks being repaired within 5 h (~ 22% residual damage) but with slower 
kinetics (T1/2 ~ 3.5 h) than wild type cells (T1/2 ~ 1.7 h) [Figure 4.4 B on page 43, also 
see table 4.3 on page 64]. BRCA2 mutant pancreatic human tumor cells Capan 1 
show no remarkable increase in the initial damage, but the majority of chromatid 
breaks (~ 80%) remains un-rejoined (Figure 4.4 C, E and F, page 43). On the other 
hand, BRCA1 mutant breast cancer human cells HCC4.12 show ~ 1.5 fold increase 
in the initial damage and leave ~ 85% chromatid breaks un-rejoined (Figure 4.4 D, E 
Results 
and F, page 43). Refer to Table 4.3 (page 64) for a comparison of residual damage 
and of the repair half times between wild type and mutant human cells.  
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Figure 4.4 Kinetics of chromatid breaks in exponentially growing human cells, irradiated 
with 1 Gy X-rays and allowed to repair for up-to 5 h after irradiation. The number of 
chromatid breaks/cell is plotted against time. (A) D-NHEJ deficient colon cancer cells, (B) 
DNA-PKcs deficient glioma cells, (C) BRCA2 deficient pancreatic tumor cells, (D) BRCA1 
deficient breast cancer cells, (E) Comparison between initial and residual chromosome 
damage in different human mutants, (F) Comparison of % residual damage (% of initial 
breaks) in different human mutants. 
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These results show that wild type human cells are more sensitive for X-rays than wild 
type rodent cells (initial number of breaks ~ 6 to 8/Gy for the former than ~ 4/Gy for 
the latter). The results obtained with D-NHEJ and HRR deficient human mutants are 
qualitatively similar to those obtained for rodent mutants. Thus, no species specific 
variability is observed for this HRR dependent repair of G2-chromosomal breaks. 
Interestingly BRCA1 deficient cells show as a strong phenotype as BRCA2 deficient 
cells, despite the fact that BRCA1 is thought to be involved in HRR only indirectly and 
possibly by reinforcing DSB generated signalling (194). The results in aggregate 
emphasize the importance of breast cancer susceptibility genes in HRR mediated 
repair of G2-chromosomal breaks. 
4.2.5 Chemical down regulation of Rad51 inhibits the repair of G2-
chromosomal breaks in wild type hamster and human cells 
Rad51 is a key protein of HRR taking part in the homology search and synapsis that 
follows the end preparation step (see Figure 2.3, page 16). Rad51 deficiency is lethal 
and as a result no Rad51 mutants or knockout cells or animals are available for 
genetic studies. PCI-24781 is an HDAC-inhibitor, which radiosensitizes tumor cells 
and is being tested clinically for application in treatment of human cancer. Adimoolam 
et al. (2007) have shown that PCI-24781 radiosensitizes human colon cancer and 
Chinese hamster cells via inhibition of HRR through down-regulation of Rad51 
protein (112).  
As HRR deficient hamster and human mutant cells show remarkable defects in the 
repair of G2-chromosomal breaks; we decided to treat selected hamster and human 
wild type and HRR mutants with PCI-24781 for 24 hours before exposure to 1 Gy X-
rays. The purpose of this experiment was to investigate whether PCI-24781 mediated 
inhibition of HRR affects the kinetics of rejoining of chromatid breaks? Exponentially 
growing CHO (wild type) and irs1SF cells are treated with 2 µM and breast cancer 
BHA (corrected cells) are treated with 0.5 µM PCI-24781 for 24 hours before 
irradiation. The results are summarized in Figure 4.5 (page 45). CHO cells show 
strong inhibition of chromatid break repair (~ 60% residual damage) when treated 
with PCI-24781 before irradiation; while cells which are only irradiated can repair the 
majority of these breaks (~ 10% residual damage). HRR deficient irs1SF cells, on the 
other hand show no significant difference in chromatid break repair when treated with  
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Figure 4.5 Effect of different inhibitors on the kinetics of chromatid breaks in exponentially 
growing Chinese hamster and human mutants. Cells were treated with the indicated 
concentrations of caffeine for 1 h and PCI-24781 for 24 h before 1 Gy X-rays and allowed to 
repair for 5 h. Drugs were maintained in the cultures during the entire postirradiation 
incubation period. (A and B) Effect of 4 mM caffeine on wild type and HRR deficient Chinese 
hamster mutants, (C, E and G) Effect of HDAC inhibitor PCI-24781 on wild type and HRR 
deficient hamster mutant, (D, F and H) Effect of HDAC inhibitor PCI-24781 on BHA human 
cells. 
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PCI-24781 in comparison of those which are only irradiated (Figure 4.5 C, E and G, 
page 45,). Human BHA cells also show nearly complete inhibition of chromatid break 
repair when irradiated after treatment with PCI-24781 (Figure 4.5 D, F and H, page 
45).  
These results confirm that inhibition of HRR, even using chemical means (PCI-
24781), abrogates chromatid break repair in G2.  
4.3  Role of DDR proteins in the repair of G2-chromosomal breaks 
DDR signalling and DSB repair pathways are thought to act in a well coordinated 
manner to detect and process IR induced DNA damage. The next question we 
wished to address was whether important DDR proteins contribute directly to the 
repair of G2-chromosomal breaks? To address this question, we employed mouse 
and human mutants defective in key components of DDR. We also employed for this 
purpose specific and non-specific chemical inhibitors. The results are summarized in 
Figure 4.6 and Figure 4.7 (page 48 and page 52 respectively). 
4.3.1 H2AX and 53BP1 defects do not affect the repair of G2-
chormosomal breaks 
H2AX and 53BP1 are early DNA damage sensing proteins, which contribute to the 
mounting of the DDR signalling cascade. To examine the role of these proteins on 
chromatid break repair kinetics we used mouse knockout cell lines. Exponentially 
growing wild type, H2AX-/- and 53BP1-/- mouse cells are irradiated with 1 Gy X-rays 
and the kinetics of chromatid break repair is determined. Both H2AX-/- (Figure 4.6 A, 
page 48) and 53BP1-/- (Figure 4.6B, page 48) cells repair chromatid breaks with 
kinetics similar to those of their wild type counterparts.  
4.3.2 The role of DNA-PK, ATM and ATR in the repair of G2-chromosomal 
breaks 
DNA-PKcs, ATM and ATR belong to the kinase family PI3KK and have been clearly 
implicated in DDR signalling. These proteins are considered as the most important 
players in G2-checkpoint response and in the maintenance of genomic stability. 
While DNA-PKcs is one of the central components of D-NHEJ, ATM and ATR are 
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thought to be principally involved in DDR signalling. To investigate the role of these 
proteins in the repair of chromatid breaks we used the DNA-PKcs deficient human 
glioma cells, M059J, the ATM mutant human fibroblasts, AT5BIVA, and the 
doxycycline inducible ATR kinase dead GM847 human cells. Results with M059J 
cells are described in detail in section 4.2.4. (page 42) Here it is important to mention 
that these cells repair chromatid breaks with slower kinetics than other D-NHEJ 
mutants (compare Figure 4.4 A and B, page 43). AT5BIVA cells show significant but 
not complete inhibition of chromatid break repair. The initial damage is ~ 2 fold higher 
than wild type cells and the % residual damage is ~ 45% with T1/2 ~ 4.2 h; the T1/2 for 
wild type cells is ~ 1.7 h (Figure 4.6 F on page 48 and Table 4.4 on page 65). 
Interestingly ATR kinase dead cells show almost complete inhibition of chromatid 
break repair with ~ 93% of residual damage after 5 h of irradiation (Figure 4.6 G, H, I 
on page 48 and Table 4.4 page 65).  
4.3.3 Nbs1 and BRCA1 defects significantly inhibit G2-chromosomal 
break repair 
Both Nbs1 and BRCA1 proteins have been shown to be important in DDR signalling. 
They are also implicated in HRR mediated signalling. The results with BRCA1 
deficient breast cancer cells are also discussed in section 4.2.4 (page 42), where it is 
shown that the repair of chromatid breaks is severely compromised in these cells 
(also see Figure 4.6 D, page 48). Nbs1 deficient human fibroblasts also show 
significant inhibition of chromatid break repair with ~ 62% residual damage left after 5 
h of irradiation (Figure 4.6 C, H and I, page 48). These results suggest that proteins 
involved in DDR signalling show remarkable defects in the repair of G2-chromosomal 
breaks. 
Please refer to Table 4.4 (page 65) for a comparison of residual damage and half 
times of repair between wild type and DDR signalling mutants. 
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Figure 4.6 Kinetics of chromatid breaks in exponentially growing mammalian cells deficient 
in DDR-signalling proteins. Cells are irradiated with 1 Gy X-rays and allowed to repair for 
up-to 5 h. The number of chromatid breaks/cell is plotted against time. (A) H2AX-/- MEFs, 
(B) 53BP1-/- MEFs, (C) Nbs1 deficient human fibroblasts, (D) BRCA1 deficient breast cancer 
cells, (E) DNA-PKcs deficient human glioma cells, (F) Human ATM mutant, (G) Doxycycline-
induced ATR kinase dead human cells,  (H) Comparison between initial and residual 
chromosome damage, (I) Comparison of % residual damage (% of initial breaks). 
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4.3.4 Transitional knock down of CtIP completely inhibits repair of G2-
chromosomal breaks in M059J cells 
CtIP, along with BRCA1 and MRE11, promotes DSB repair through HRR by 
contributing to DNA end resection that produces the recombinogenic 3’ single 
stranded DNA tails (91,92). CtIP interacts with the MRN complex and enhances 
MRE11’s endo-nuclease activity for ssDNA, indicating that MRN functions at the 
initiation step of HRR by promoting DSB end resection through its interaction with 
CtIP. In this experiment we transitionally knocked down CtIP with the help of siRNA 
in DNA-PKcs deficient M059J cells. Cells in which CtIP had been knocked down 
show complete inhibition of chromatid break repair with ~ 98% residual damage at 5 
h post irradiation (Figure 4.7D on page 52 and Table 4.5 on page 66).  
4.3.5 Chemical inhibition of MRE11 inhibits repair of G2-chromosomal 
breaks in D-NHEJ deficient cells 
LIG4-/- HCT116 cells were treated with 30, 50 and 100 µM of MIRIN (MRE11 
inhibitor) for 1 h before 1 Gy of X-rays. Only irradiated cells are taken as control for 
this experiment. As shown in Figure 4.7 E (page 52), MIRIN inhibits the repair of 
chromatid breaks significantly in a concentration independent manner.  
4.3.6 Effect of caffeine on the repair of G2-chromosomal breaks 
The results presented above clearly show that ATR plays a very important role in 
HRR mediated repair of G2-chromosomal breaks, while ATM deficiency shows a less 
pronounced effect. DNA-PKcs deficient human glioma cells show normal but slow 
repair of chromatid breaks. We were interested to further look into the role of ATM 
and ATR in the repair of chromatid breaks using caffeine. Caffeine has been shown 
to radiosensitize hamster cells by targeting HRR (195). It is also known to inhibit 
ATM, ATR and DNA-PKcs in vitro (189), and is therefore considered a non-specific 
inhibitor of signalling proteins of the PI3KK family. In this experiment we examined 
the effect of caffeine on the kinetics of chromatid break repair in selected wild type, 
HRR and D-NHEJ mutants of hamster and human origin. Exponentially growing cells 
were treated with 4mM caffeine for 1 h before 1 Gy X-rays and prepared for 
cytogenetic analysis following different post irradiation incubation times. While no 
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additional effect of caffeine is observed on the kinetics of chromatid break repair in 
HRR deficient irs1 and irs1SF cells, the repair is partially inhibited in wild type CHO 
and V79 cells (Figure 4.5 A and B, page 45). Caffeine inhibits the repair of chromatid 
breaks almost completely (~ 80% residual damage) in the DNA-PKcs deficient 
human glioma cells M059J (Figure 4.7 A, F and G, page 52), while the wild type 
M059K cells show partial repair inhibition (Figure 4.7 A, H and I, page 52). Results 
with caffeine-treated irs1 and irs1SF cells are in agreement with the hypothesis that 
caffeine inhibits HRR and this is why an additional effect is not observed. Results 
with DNA-PKcs deficient M059J cells suggest that almost complete inhibition of 
chromatid break repair in these cells is due to the inhibition of ATM and ATR. It 
should be noted that low levels of ATM are reported in M059J cells (196,197). 
M059K cells show only partial inhibition of chromatid break repair when treated with 4 
mM caffeine before irradiation, which suggests that either caffeine does not inhibit 
HRR completely at this dose, or that B-NHEJ repairs these breaks. To check this 
possibility, we treated cells with the PARP-1 inhibitor PJ34. PARP-1 is a candidate 
component of B-NHEJ. M059J and M059K cells were treated with a combination of 
10 µM PJ34 (PARP1-inhibitor) and 4mM caffeine for 1 h before exposure to 1 Gy X-
rays. No additional effect of PJ34 is observed on the kinetics of chromatid breaks in 
either cell line (Figure 4.7 F, G, H and I, page 52). 
4.3.7 Effect of a specific ATM inhibitor on the repair of G2-chromosomal 
breaks  
Caffeine is a non-specific inhibitor of PI3K kinase family. To explore the exact role of 
the ATM kinase in the repair of chromatid breaks in human glioma and colon cancer 
cells, we used the specific ATM inhibitor, KU55933. Exponentially growing cells were 
treated with 10 µM KU55933 for 1 h before exposure to 1 Gy X-rays. The inhibitor 
was maintained in the cultures during the entire period of repair incubation. The 
kinetics of chromatid break repair is studied for up-to 5 h post irradiation. KU55933 
significantly inhibits repair of chromatid breaks with ~ 80% residual damage in M059J 
cells and partially in M059K cells with ~ 20% residual damage (Figure 4.7 B on page 
52 and Table 4.5 on page 66).  
KU55933 also inhibits repair of chromatid breaks in DNA-PKcs knockout human 
HCT116 colon cancer cells (~ 67% residual damage), but has no effect on wild type 
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HCT116 cells (Figure 4.7 C on page 52 and Table 4.5 on page 66). These results 
suggest that although the ATM levels are low in M059J cells, these low levels are 
enough to signal and support repair of the majority of chromatid breaks in the 
presence of a functional ATR. Specific (KU5933) or non-specific (caffeine) inhibition 
of ATM significantly compromises repair in these cells. The same applies also to 
HCT116 DNAPK-/- cells, which are shown to have low levels of ATM (Mladenov E., 
unpublished data). The results with M059K cells suggest that inhibition of ATM alone 
can not inhibit repair of chromatid breaks completely, which emphasizes on the 
importance of ATR in this response. We have no explanation for the results obtained 
with HCT116 wild type cells.  
4.4  Does the G2-checkpoint play a role in the repair of G2-
chromosomal breaks? 
DSBs are potent inducers of cell cycle checkpoints mediated through DDR signalling. 
G2-M checkpoint activation delays/stops cell division to facilitate repair. The G2-
checkpoint is the last chance to correct genomic damage prior to cell division. DDR 
signalling proteins of PI3K kinase family, DNA-PKcs, ATM and ATR have been 
shown to be the key players in the activation of this checkpoint. In the cytogenetic 
assay described before, chromatid breaks are scored at metaphase, which means 
that irradiated G2-cells are allowed to progress through the cell cycle and to reach 
metaphase and that during this process cells are under the influence of the G2-
checkpoint. Assuming that the G2-checkpoint stops cell cycle progression and 
facilitate the repair of DSBs, the question arises as how and why HRR deficient cells 
leave the majority of chromosome breaks unrepaired? To study the influence of G2-
checkpoint on the repair of G2-chromosomal breaks we decided to perform calyculin-
A induced premature chromosome condensation (PCC) in wild type and HRR 
mutants of Chinese hamster and human origin. We also checked the G2-checkpoint 
activation, maintenance and recovery employing flow cytometric methods in wild 
type, D-NHEJ and HRR mutants to systematically address this issue. The results 
obtained are described in the following sub-sections. 
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Figure 4.7 Effect of different inhibitors on the kinetics of chromatid breaks in wild type and 
NHEJ deficient human cells. Exponentially growing cells were treated with the indicated 
concentrations of different inhibitors, alone or in combination, for 1 h before exposure to 1 
Gy of X-rays. Drugs were maintained in the cultures for the entire period of the experiment. 
Treated cells were allowed to repair for 5 h. Chromatid breaks/cell is plotted against time. 
(A) Effect of caffeine and PJ34 on DNA-PKcs deficient glioma cells, (B and C) Effect of ATM 
inhibitor KU55933 on DNA-PKcs deficient human glioma and colon cancer cells, (D) Effect 
of transitional CtIP knockdown on DNA-PKcs deficient glioma cells, (E) Effect of mirin on 
LIG4-/- colon cancer cells,(F and H) Comparison between initial and residual damage in 
M059J and K cells after different treatments, (G and I) Comparison of % residual damage 
(% of initial breaks) in M059 J and K cells after different treatments. 
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4.4.1 The repair of G2-chromosomal breaks is influenced by the G2 
checkpoint 
Calyculin-A induces condensation of chromatin in interphase cells. A great 
advantage of this approach is that damage can be visualized and scored directly in 
G2 cells, which eliminates the influence of the G2 checkpoint on repair. G2-PCCs 
can easily be distinguished from metaphase chromosomes as they lack the 
centromeric constrictions (Figure 4.8 and 4.9 A, B, C, and D, page 54). In this 
experiment exponentially growing wild type and HRR mutants are irradiated with 1 or 
2 Gy X-rays and G2-PCC break kinetics measured for up to 4 h post irradiation. The 
results of CHO cells are shown in Figure 4.8 (page 54). Surprisingly, the initial level 
of damage is found similar in both WT and HRR deficient cells. While wild type cells 
repair normally, the majority of breaks are left un-rejoined in HRR deficient cells 
(Figure 4.8 E and F, page 54).  
Wild type and HRR deficient human cells also show the same level of initial induction 
of chromosome breaks, but compromised repair in the presence of HRR defects 
(Figure 4.9 E and F, page 55). BRCA2 deficient Capan1 cells show excessive 
damage when irradiated with 2 Gy. Therefore, to facilitate scoring we irradiate also 
with 1 Gy. The results of PCC measurements confirm our results obtained with 
metaphase chromosome break analysis showing the importance of functional HRR in 
the repair of IR induced G2-chromosomal breaks. The similar level of damage 
induction and the different kinetics of rejoining in WT and HRR mutants suggest that 
the G2 checkpoint is playing an important role in this repair process and probably 
works inefficiently in HRR deficient cells. To address the latter possibility we 
examined systematically G2-checkpoint activation and recovery in wild type and 
repair deficient cells, which is discussed in the next sections. 
 
Results 
 
 
 
 
 
54
Figure 4.8 Kinetics of calyculin-A induced G2-PCC breaks in exponentially growing wild 
type and HRR-deficient Chinese hamster mutants irradiated with 2 Gy X-rays. Cells were 
allowed to repair for up-to 4 h. G2-PCCs were induced by adding 50 nM calyculin A for 45 
minutes and this time is included in the repair time. G2-PCC breaks/cell is plotted against 
time. (A, B, C and D) Calyculin A induced G2-PCC breaks in CHO and HRR deficient irs1SF 
cells at different post irradiation times; arrows represent PCC-breaks and arrow heads 
represent chromatid exchanges, (E and F) Kinetics of G2-PCC breaks in wild type and HRR 
deficient Chinese hamster mutants. 
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Figure 4.9 Kinetics of calyculin-A induced G2-PCC breaks in exponentially growing wild 
type, and BRCA1 or BRCA2 deficient human cells. Cells were irradiated with 1 or 2 Gy X-
rays and allowed to repair for up-to 4 h. G2-PCCs were induced by adding 50 nM Calyculin-
A for 45 minutes and this time is included in the repair time. G2-PCC breaks/cell is plotted 
against time. (A, B, C, D) Calyculin A induced G2-PCC breaks in BHA and Capan1 cells at 
different post irradiation times, arrows represent PCC-breaks, (E) Kinetics of G2-PCC 
breaks in BHA and BRCA2 mutant human pancreatic tumor cells, (F) Kinetics of G2-PCC 
breaks in wild type and BRCA1 mutant breast cancer cells. 
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4.4.2 Study of G2-checkpoint activation and recovery in wild type, D-
NHEJ and HRR mutants 
Checkpoint activation alters the normal distribution of cells through the cell cycle, 
which can be easily detected by DNA content variations in flow cytometry analysis. 
This technology is employed here to determine the accumulation of irradiated cells at 
the G2-M border. Mitotic index (MI) variations also reflect the G2 checkpoint 
activation and provide a higher sensitivity of detection than G2 phase accumulation. 
Histone H3 is phosphorylated at Serine-10 (Histone-H3 pS10) early in mitosis and, 
therefore an antibody against phospho-histone H3 can be used to assess the IR-
induced G2 checkpoint delay or entry into mitosis (187). Histone-H3 pS10 staining is 
very specific for mitotic cells (Figure 4.10 A and Figure 4.11 A, page 59 and page 60 
respectively). 
4.4.2.1  G2-M accumulation after IR in wild type and repair deficient cells 
Exponentially growing wild type, D-NHEJ and HRR deficient hamster cells are 
irradiated with 2 Gy X-rays and the G2-M fraction is determined by flow-cytometry for 
up to 24 h post irradiation. During analysis we determined the relative G2-M fraction 
at each time point, instead of taking the absolute % of G2-M cells. This normalization 
is done through dividing the %G2-M fraction at any given time by the %G2-M fraction 
of the corresponding un-irradiated control. Results with CHO cells are summarized in 
Figure 4.10 B (page 59). CHO cells show strong accumulation in G2-M border, which 
reaches a maximum (at ~4 times the 0 h value) at 6 h post irradiation, indicating that 
cells stopped in G2 as a result of the activation of the G2-checkpoint. Subsequently, 
the percent G2-M fraction starts decreasing and reaches normal levels at 24 h, 
indicating the recovery from the G2-M checkpoint. D-NHEJ deficient xrs5 cells show 
~2.5 times maximum increase at 6 h and recover within 24 h. In contrast, irradiated, 
HRR deficient irs1SF cells show almost no accumulation in G2-M. The results with 
wild type V79 and HRR deficient irs1 cells on the other hand show ~ 2 times increase 
in G2-M fraction at 8 hours, and recovery to normal levels within ~16 h (Figure 4.10 
C, page 59). Thus, the G2-checkpoint defect in HRR deficient cells may be cell 
line/mutation specific. 
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4.4.2.2  Analysis of the G2-checkpoint in Chinese hamster cells through 
measurement of mitotic index (MI) 
As described in the section 4.4.2.1 (page 56), flow-cytometric determination of % G2-
M fraction gives information of G2-checkpoint activation and recovery, but the 
method is not sensitive enough to allow firm conclusions. As a next step, we studied 
therefore the G2-checkpoint by determining mitotic index through flow-cytometry. 
This type of measurement allows evaluation of the kinetics of cell recovery or escape 
from the G2 checkpoint and reflects for short post-irradiation times exclusively the 
response of cells irradiated in G2. As a result a direct comparison with the kinetics of 
chromosome break repair is possible. 
In these experiments we used a wide spectrum of Chinese hamster wild type, D-
NHEJ and HRR mutants, as well their corrected counterparts. Exponentially growing 
cells were irradiated with 1 Gy X-rays and the mitotic index was determined for up-to 
5 h post irradiation by staining for Histone-H3 pS10. This staining allows the 
estimation of the % of mitotic cells at each time point.  
CHO cells show a rapid decrease in the % mitotic cells within 1 h post irradiation 
(~90% decrease), which is maintained up-to 2 h. Subsequently the % mitotic cells 
increases and reaches 100% at 4 h post-irradiation. D-NHEJ deficient xrs5, XR1 and 
V3 cells show the similar rapid decrease in % mitotic cells and even prolonged delay 
in recovery, which resembles the stronger G2-checkpoint in these cells (Figure 4.10 
D, page 59). When compared with wild type CHO cells, HRR deficient cells irs1SF 
and Rad51D1 show remarkable defects in G2 checkpoint activation and recovery. 
The corrected irs1SF cells (Clone X5-1) show almost normal decrease and recovery 
of % mitotic cells (Figure 4.10E, page 59).  See Figure 4.12 (page 61) for a 
comparison of density plots between CHO, irs1SF and V3 cells.  
To further check the generality of these results we employed HRR deficient Chinese 
hamster fibroblast cells irs1, irs2 and irs3 along with wild type V79 and corrected 
clone irs1 cells. BRCA2 mutant V-C8 cells are also employed. V79 cells show 
maximal decrease in % mitotic cells (~80% decrease) at 1 h post irradiation and 
rapidly resume normal levels within 2 h. irs1 cells show a remarkable defect in G2-
checkpoint activation and recovery when compared with wild type V79 and the 
corrected clone1 (Figure 4.10 F, page 59). irs2, irs3 and V-C8 cells also show clear 
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defects in G2-checkpoint activation (Figure 4.10 G, page 59). These results suggest 
that Rad51 dependent HRR is essential for the full development of the G2-
checkpoint. They also provide an explanation for the lack of repair of chromatid 
breaks in HRR deficient cells. This is the first report showing a connection between 
HRR and G2-checkpoint activation.  
4.4.2.3  Study of the G2-checkpoint in BRCA1 and BRCA2 deficient 
human cells by measuring mitotic index (MI) 
We investigated G2-checkpoint response in HRR deficient human cells lines. BRCA2 
deficient cells do not show any difference in reduction and recovery of % mitotic cells 
when compared with their vector control BHA. But interestingly they show significant 
G2-checkpoint defect when compared with A549 human tumor cells (Figure 4.11 B, 
page 60). BRCA1 deficient cells show a clear defect in G2-checkpoint activation in 
comparison to their vector control and A549 cells (Figure 4.11C, page 60). MEFs 
homozygous for a targeted deletion of exon 11 of the Brca1 gene have been shown 
to maintain an intact G1-S checkpoint but are defective in the IR-induced G2-M 
checkpoint (86). Reduced G2-arrest was observed in irradiated cells of breast cancer 
patients as compared to normal controls (198). 
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Figure 4.10 Study of G2-checkpoint activation, (A) Density plot displaying Histone-H3 pS10 
positive (mitotic) population inside the rectangle, (B and C) G2-M fraction as determined by 
calculating DNA content using flow-cytometry after exposure to 2 Gy X-rays, (D) Mitotic 
index determination in D-NHEJ deficient cells, (E) Mitotic index determination in HRR 
deficient CHO mutants, (F and G) Mitotic index determination in HRR deficient Chinese 
hamster fibroblast mutants. Exponentially growing cells are irradiated with 1 Gy X-rays for 
mitotic index determination. 
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Figure 4.11 Study of G2 checkpoint in wild type, BRCA1 and BRCA2 deficient human cells 
by flow cytometry. Exponentially growing cells are irradiated with 1 Gy X-rays and mitotic 
index is determined for up-to 5 h postirradiation. Histone H3-pS10 staining was employed. 
(A) Confocal image showing Histone H3-pS10+ve mitotic cells [FITC, Green], non mitotic 
cells are stained with PI only [Red],  (B) Mitotic index determination in wild type and BRCA2 
mutant cells, (C) Mitotic index determination in  wild type and BRCA1 mutant cells. 
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Figure 4.12 Study of G2-checkpoint activation and recovery in wild type, HRR and D-NHEJ 
mutants of Chinese hamster ovary origin. Exponentially growing cells are irradiated wit
Gy X-rays and mitotic index is determined by flow cytometry at different post-irradiation 
times, as indicated in the density plots. Histone-H3 pS10 staining is used as a marker of the 
mitotic population (indicated inside the rectangle in the density plots). 
h 1 
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Table 4.1: Residual chromatid breaks at 5 h post irradiation (% of initial 
breaks), and half times of repair of chromosome breaks in different Chinese 
hamster WT, NHEJ and HRR mutants irradiated with 1 Gy X-rays 
S/No. Species Cell line 
name 
Mutation Residual chromatid 
breaks (% of initial 
breaks) 
Half Repair 
time T1/2 (h) 
1 Chinese 
hamster 
CHO10B4 WT 10% 2 h 
2 Chinese 
hamster 
Xrs5 Ku80 11.8% 2.5 h 
3 Chinese 
hamster 
V79 WT 7.5% 2 h 
4 Chinese 
hamster 
Irs20 DNA-PKcs 7.6% 2 h 
5 Chinese 
hamster 
Irs20k147E Corrected for 
DNA-PKcs 
10% 2 h 
6 Chinese 
hamster 
XR1 XRCC4 14.7% 3.3 h 
7 Chinese 
hamster 
Irs1SF XRCC3 78% (∞) 
8 Chinese 
hamster V79 
Irs1tor XRCC2 81% (∞) 
9 Chinese 
hamster V79 
Irs1clone1 Corrected for 
XRCC2 
12.7% 2 h 
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Table 4.2: Residual chromatid breaks at 5 h post irradiation (% of initial breaks) 
and half times of repair in different MEF WT, NHEJ and HRR mutants irradiated 
with 1 Gy X-rays 
S/No. Species Cell line 
name 
Mutation/knockout Residual chromatid 
breaks (% of initial 
breaks) 
Half Repair 
time T1/2 (h) 
1 Mouse MEFLig4+/+ WT 16% 2.4 h 
2 Mouse MEFLig4-/- Lig4 14% 3 h 
3 Mouse MEF347E Rad54 51.8% 4.5 h 
4 Mouse MEF347B Lig4 & Rad54 71% (∞) 
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Table 4.3: Residual chromatid breaks at 5 h post irradiation (% of initial breaks) 
and half times of repair in different human WT, NHEJ and HRR mutants 
irradiated with 1 Gy X-rays 
S/No. Species Cell line 
name 
Mutation/ 
knockout 
Residual chromatid breaks 
(% of initial breaks) 
Half Repair 
time T1/2 (h) 
1 Human BHA WT 17.6% 2.7 h 
2 Human Capan1 BRCA2 78.5% (∞) 
3 Human HCC4.10 WT 21% 3 h 
4 Human HCC4.12 BRCA1 85% (∞) 
5 Human M059K WT 2.15% 1.7 h 
6 Human M059J DNA-PKcs 22% 3.5 h 
7 Human HCT116 WT 17.6% 3 h 
8 Human HCT116 DNA-PKcs 31% 3.2 h 
9 Human HCT116 Lig4 30% 4 h 
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Table 4.4: Residual chromatid breaks at 5 h post irradiation (% of initial breaks) 
and half times of repair in different cells deficient in important DDR signalling 
proteins irradiated with 1 Gy X-rays 
S/No. Species Cell line 
name 
Mutation/ 
knockout 
Residual chromatid breaks 
(% of initial breaks) 
Half Repair 
time T1/2 (h) 
1 Human M059K WT 2.15% 1.7 h 
2 Human M059J DNA-PKcs 22% 3.5 h 
3 Mouse H2AX+/+ WT 16% 2.5 h 
4 Mouse H2AX-/- H2AX-/- 18.3% 3 h 
5 Mouse 53BP1+/+ WT 16% 2.5 h 
6 Mouse 53BP1-/- 53BP1-/- 20% 2.5 h 
7 Human M059K WT 2.15% 1.7 h 
8 Human AT5BIVA ATM 45% 4.2 h 
9 Human NBS1 LB Nbs1 62% (∞) 
10 Human GM-847 WT 14.5% 1.5 h 
11 Human GM-
847ATRkd 
ATR kinase 
dead 
93% (∞) 
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Table 4.5: Residual chromatid breaks at 5 h post irradiation (% of initial breaks) 
and half times of repair in DNA-PKcs deficient human cells treated with 
different inhibitors before irradiation with 1 Gy X-rays 
S/No. Species Cell line 
name 
Mutation/ 
knockout 
Treatment Residual chromatid 
breaks (% of initial breaks) 
Half Repair 
time T1/2 (h) 
1 Human M059K WT 1Gy 2.15% 1.7 h 
2 Human M059J DNA-PKcs 1Gy 22% 3.5 h 
3 Human HCT116 WT 1Gy 17.6% 3 h 
4 Human HCT116 DNA-PKcs 1Gy 31% 3.2 h 
5 Human HCT116 DNA-PKcs 10uM 
Ku55933+1Gy 
67% (∞) 
6 Human HCT116 DNA-PKcs 4mM caffeine +1Gy 46.12% (∞) 
7 Human M059J DNA-PKcs 10uM 
Ku55933+1Gy 
77.9% (∞) 
8 Human M059J DNA-PKcs Transitional CtIP 
knock down+1Gy 
97.6% (∞) 
 
9 
Human M059J DNA-PKcs 4mM caffeine+1Gy 75.7% (∞) 
10 Human M059J DNA-PKcs 10uM PJ34+4mM 
caffeine+1Gy 
81% (∞) 
11 Human M059K WT 4mM caffeine+1Gy 16.6% 2 h 
12 Human M059K WT 10uM PJ34+4mM 
caffeine+1Gy 
11.4% 2.2 h 
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5.  Discussion 
5.1  The role of D-NHEJ in the repair of G2-chromosomal breaks  
D-NHEJ is an efficient but error-prone repair process that directly rejoins broken DNA 
ends. Although it restores integrity in the DNA, it is not equipped to restore the 
sequence in the vicinity of the DSB (199) and results frequently in the loss of genetic 
information. Furthermore, as the end joining process is indiscriminate and there are 
no mechanisms in place to ensure the rejoining of the original ends, chromosomal 
rearrangements ensue when the ends of unrelated molecules/chromosomes are 
joined together (200).  
For the human and the mouse immune systems, D-NHEJ is the central DNA repair 
mechanism supporting V(D)J recombination (118). Despite its error-prone nature, D-
NHEJ is considered the main pathway of DSB repair in higher eukaryotes. One of the 
main reasons for this development may be that mammalian genomes are large and 
the first preference after breakage is to restore integrity using a fast repair process 
such as D-NHEJ.  
Our results of the repair kinetics of chromatid breaks in D-NHEJ mutants support this 
notion, as in the absence of functional D-NHEJ; more DSBs are converted to 
chromatid breaks (~2 to 3 fold increase as compared to wild type cells). This shows 
that D-NHEJ is important in maintaining genomic integrity in mammalian cells via 
repair of the bulk of DSBs. On the other hand, no defect is observed in the kinetics of 
chromatid breaks in D-NHEJ deficient cells, as in the metaphases scored for up to 5 
h after irradiation, their numbers decrease with kinetics similar to those measured in 
wild type cells. This observation suggests that D-NHEJ is not contributing to the 
repair of the subset of DSBs causing G2 chromosome breaks. In addition, since the 
mitotic index drops significantly after irradiation in D-NHEJ mutants, the unchanged 
repair kinetics also reflect only a subset of the cells that would have entered mitosis 
in the absence of radiation. More work and further analysis will be required to clarify 
these issues and address the real contribution of D-NHEJ to chromosome break 
repair.  The results with D-NHEJ deficient cells contrast those of HRR deficient cells, 
where a strong reduction in the ability to repair G2 chromosome breaks was 
observed.  
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5.2  HRR is required for the repair of G2-chromosomal breaks 
HRR is an error free pathway for the repair of DSBs (201), which prevents 
chromosomal deletions and rearrangements. RAD51 paralogs act as genomic 
caretakers by playing a central role in HRR. They are involved in DNA damage 
recognition, strand invasion into an undamaged DNA template, branch migration and 
resolution of Holliday junctions (202,203). Rad51 paralogs are clearly implicated in 
the prevention of HPRT gene mutations and DHFR gene amplification, which lead to 
carcinogenesis (204). Many proteins involved in HRR are products of hereditary 
cancer predisposition genes, implying that failure to adequately regulate HRR, and 
the consequent genomic instability, plays a causal role in cancer.  
The critical role of HRR in suppressing genomic instability is reflected in the early 
embryonic lethality of mice lacking Rad51, BRCA1 or BRCA2. The abundance of 
chromatid type of aberrations observed in such mutant cells suggests that the major 
function of these genes is to control sister chromatid recombination (205,206). The 
reduced Rad51 foci formation and severely impaired HRR in Rad51 paralog mutants 
also suggests an important role for the paralogs in assisting Rad51 during HRR 
(207).  
Mammalian cells deficient in HRR paralogs have been shown to be significantly 
radiosensitive (167,168). The relatively high radio-resistance of NHEJ-defective 
mutants in the late S/G2 portion of the cell cycle further suggests that HRR promotes 
survival when sister chromatids are present (169,170). While the importance of HRR 
has been clearly shown for the repair of site directed chromosomal double strand 
breaks induced by the endonuclease I-SceI (177,178), its contribution to the repair of 
IR induced DSBs remains controversial (173-175). HRR does not seem to play any 
detectable role in the repair of the bulk of DSBs induced by IR even in the G2-phase 
of the cell cycle (122).  
Despite the fact that HRR is important for genomic stability, its role in the repair of IR 
induced DSB is unclear. Our results of the kinetics of chromatid breaks in HRR 
deficient mammalian cells clearly demonstrate the absolute necessity of HRR for the 
repair of G2-chromosomal breaks in a species independent manner. This means that 
HRR is responsible at a minimum for the repair of those few specific DSB, which are 
the precursors of chromosome breaks. Due to their low numbers, these DSBs may 
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remain undetected by physical methods of measuring DSB repair like Pulsed field gel 
electrophoresis (PFGE).  
Although D-NHEJ is shown to be functional throughout the cell cycle, it does not 
seem to take part an obvious to the repair of G2 chromosome breaks, even when 
HRR is not functional. This suggests that that these DSBs are specifically processed 
by the error free HRR pathway. This may be highly appropriate when considering 
that un-repaired or miss-repaired chromosomal breaks may lead to cell death. Also 
sequence restoration at these damaged sites may also be an additional essential 
requirement.  
These are the first results showing a direct role of HRR in the repair of IR induced 
chromosomal breaks. One possible mechanism underlying this pathway selection is 
that DNA ends are resected in G2 phase to produce 3’ single stranded tails, which 
initiates HRR. The same processes may exclude the NHEJ repair machinery from 
occupying the DNA ends (208,209). When HRR is initiated but not completed due to 
defects in key proteins like Rad51 paralogs, BRCA1 and BRCA2 (202,203); a 
complete inhibition of chromosome repair is observed. Thus the un-repaired 
chromosome breaks seen in our experiments most likely to reflect DSBs whose 
repair by HRR was abrogated. The properties of this fraction of DSBs remain to be 
elucidated. 
5.3  The impact of DDR signalling on HRR mediated repair of G2-
chromosomal breaks 
5.3.1 ATR and NBS1 are more important than ATM in HRR mediated 
repair of G2-chromosomal breaks 
In the canonical model of DSB signalling ATM is considered as the primary kinase 
responsible for detecting and signalling this form of DNA damage (210), while ATR is 
thought to signal for UV induced damage and stalled DNA replication forks 
(61,63,211). Although ATM has long been implicated in signalling IR-induced DSBs, 
new data suggest that ATR also functions in IR induced DNA damage signalling  
(60,62,80,212). A novel concept of ATM dependent ATR activity has also been 
advanced by various groups (213-217).  
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Mutation in BRCT, FHA or MRE-11 binding domain of NBS1 decreased HRR activity 
as measured by a GFP based HR assay. NBS cells expressing these mutated NBS1 
forms cannot form DSB-induced MRE11 foci. These results indicate that the 
recruitment of MRE11 to the DSB sites by NBS1 is important for HRR activity. On the 
other hand, mutation in ATM-phosphorylating of ATM-binding sites did not influence 
HRR activity. Moreover, AT cells showed HRR activity at a similar level as ATM 
complemented cells, suggesting that ATM might be dispensable for HRR (110).  
Our results on the kinetics of chromatid breaks in the ATM mutants, AT5BIVA and 
cells expressing kinase dead ATR show that while repair of chromatid breaks is 
significantly compromised in ATM mutants (~ 45% residual damage), it is inhibited 
almost completely in ATRkd cells with ~ 93% residual damage (See section 4.3.2, 
page 46). One should consider that ATRkd cells are unable to repair chromatid 
breaks in spite of having normal ATM levels, while AT5BIVA cells could repair ~ 55% 
breaks, with normal ATR levels. These results suggest that ATR plays a more 
important and indispensable role than ATM in HRR. This is in line with a previous 
report where ATR/Chk1 over-expression was shown to prolong G2 accumulation and 
to increase survival of ATM deficient cells (85). Recent work carried out in our 
laboratory also shows an indispensable role of ATR in the activation and 
maintenance of IR induced G2-checkpoint (Fan, X unpublished data). Nbs1 mutant 
cells also show a stronger phenotype than ATM in terms of HRR mediated repair of 
G2-chromosomal breaks (See section 4.3.3, page 47). 
5.3.2 H2AX and 53BP1 deficiency does not affect HRR mediated repair of 
G2-chromosomal breaks 
H2AX and 53BP1 are clearly implicated in the early response to IR induced DSBs. 
H2AX has been shown to contribute to HRR in an MDC1 dependent manner, while 
53BP1 has been shown to be involved in XRCC4 dependent NHEJ (107,217).  
Our results of chromatid break kinetics in H2AX and 53BP1 knockout cells show 
normal repair of chromatid breaks. Results with 53BP1 knockout cells confirm its role 
in pathways other than HRR but results with H2AX knockout cells are surprising as 
no defect can be observed on HRR mediated repair of G2-chromosomal breaks (See 
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section 4.3.1, page 46). However involvement of this protein in HRR has been 
reported for the repair of I-SceI induced DSBs (107). 
5.4  Influence of G2-checkpoint on HRR mediated repair of G2-
chromosomal break 
5.4.1 The G2-checkpoint plays an important role in the repair of G2 
chromosomal breaks 
Our G2-PCC results in Chinese hamster and human cells deficient in HRR clearly 
show the influence of the G2-checkpoint on the repair of chromatid breaks. While a 
similar level of initial damage is induced in wild type and HRR mutants, the majority 
of PCC breaks remain un-rejoined in the latter (See section 4.4.1, page 53). These 
results suggest that the G2 checkpoint facilitates the repair of chromosome breaks in 
wild type cells but it does not seem to work properly in the absence of HRR. 
5.4.2 Proper G2-checkpoint response is dependent on functional HRR 
Classically, DSB repair and cell cycle checkpoints are considered as two different 
means for maintaining genomic stability (218-221). In higher eukaryotes, the 
signalling response to DSBs is centred on ATM, ATR and DNA-PK. These PI3K 
kinases trigger cell cycle arrest following DNA damage, and are thought to provide in 
this way time for the cells to repair. While ATM and ATR act as initiators of DNA 
damage checkpoint signalling (222), DNA-PKcs has a critical role in DSB repair via 
NHEJ (200). The breast cancer associated gene BRCA1 has also been shown to be 
required for G2 checkpoint control, as well as for HRR mediated repair of DSBs 
(86,87). ATM defects impair HRR-mediated DSB repair and may link cell cycle 
checkpoints to HRR activation (223).  
Our results on the G2 checkpoint using Histone-H3 pS10 staining reveal a novel role 
of the HRR machinery in the activation and maintenance of this checkpoint. Chinese 
hamster cells deficient in Rad51 paralogs Rad51B, Rad51C, Rad51D, XRCC2 and 
XRCC3 as well in BRCA2 show a remarkable defect in G2-checkpoint activation, 
while Ku80, DNA-PKcs and XRCC4 deficient cells show strong G2-checkpoint 
activation and delayed recovery as compared to WT cells (See section 4.4.2.2, page 
57). The XRCC2 and XRCC3 complemented cells resume G2- checkpoint activation 
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and recovery to levels similar to WT cells. These results link HRR to the IR induced 
G2-checkpoint signalling and impose a requirement for HRR function to achieve full 
G2-checkpoint activation. This requirement goes over and above the requirement for 
DDR signalling proteins ATM and ATR, which have long been shown to be 
associated with G2-checkpoint responses. The strong G2-checkpoint activation and 
delayed recovery in NHEJ deficient cells suggests that this delay in cell cycle 
progression facilitates repair via HRR in these cells. 
These results provide the possible explanation for the lack of G2-chromosomal break 
repair in HRR deficient cells and suggest that checkpoints and repair pathways do 
not work independently, but co-operate instead to ensure genomic stability.  
How signalling proteins like ATM and ATR fail to activate G2-checkpoint in HRR 
deficient cells, needs to be investigated in detail. Our results of chromatid break 
kinetics in ATM mutant and ATRkd cells, as well as recent data from another study 
from our lab (Fan, X unpublished data) implicate ATR in this response. 
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6.  Conclusions 
Our results show absolute requirement for HRR in the repair of G2 chromosomal 
breaks and emphasize its importance in the activation and maintenance of the G2-
checkpoint.  
While D-NHEJ is responsible for the repair of majority of IR induced DSBs in 
mammalian cells, HRR is critically involved in the repair of a fraction of DSBs which 
can be converted to chromatid breaks. If left unrepaired or if misrepaired, these 
DSBs can compromise cell survival and initiate genomic instability.  
Defects in DDR signalling proteins that are also implicated directly or indirectly in 
HRR show a strong inhibition in the repair of G2-chromosomal breaks. Notably, ATR 
plays an indispensable role in the repair of these breaks. 
Full G2-checkpoint activation after IR exposure is dependent on functional HRR 
machinery. These results suggest that the purpose of G2-checkpoint activation is 
more likely to facilitate repair of the fraction of DSBs that are processed by HRR and 
thus require more time for their repair, as HRR is considered to be a slow process 
when compared to D-NHEJ.  
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8.    Appendix  
Appendix 1: Buffers and solutions 
1. 1X Phosphate Buffered Saline (PBS) 
Dissolve the following in 800ml Double distilled water (ddH2O). 
• 8 g of NaCl 
• 0.2 g of KCl 
• 1.44 g of Na2HPO4 
• 0.24 g of KH2PO4 
Adjust pH to 7.4. 
Adjust volume to 1 L with additional ddH2O. 
Sterilize by autoclaving and store at 4°C. 
 
2. Trypsin-EDTA (Trypsin0.05%, EDTA 0.02%) 
0.5 g of Trypsin 
0.2 g of EDTA 
Adjust the volume to 1 L with 1X PBS. 
Sterilize by passing through 0.22 μm filter and store at -20°C 
 
3. 100X Propidium iodide. (4 mg/ml) 
400mg of PI 
Adjust the volume to 100 ml with ddH2O. 
Store at -20°C in dark. 
 
 
 
 
Appendix 
 
95
4. 100X RNase  (6.2 mg/ml) 
620 mg of RNase 
Adjust the volume to 100 ml with ddH2O 
Store at -20°C in dark. 
 
5. FACS Permeabilization solution (PBS + 0.25% Triton X-100) 
2.5 ml Triton X-100 
Adjust the volume to 1000 ml with PBS. 
Store the solution at RT in dark. 
 
6. FACS blocking buffer (PBS + 0.05% Tween-20 + 1% BSA) 
10 g BSA 
2.5 ml 20% Tween-20 
Adjust the volume to 1000 ml with PBS. 
Store at -20°C. 
 
7. Hypotonic solution 
0.56 g KCl 
Adjust the volume to 100ml with ddH2O 
Prepare fresh at the time of experiment 
 
8. Carnoy’s fixative (3 parts Methanol + 1 part acetic acid) 
75 ml methanol 
25 ml acetic acid 
Prepare fresh at the time of experiment 
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Appendix 2:  Settings for cell cycle analysis 
Cell cycle analysis programme settings 
Flow cytometry: COULTER EPICS XL 
Sheath Speed: middle 
Total cells sampled: 20000 
Maximal running duration: 900 seconds 
Working mode: carousel 
Excitation (nm): 488  
Filter spectrum (nm): 655-735  
FS-PMT (volt): 55  
FS-Gain: 2  
SS-PMT (volt): 400  
SS-Gain: 1  
AUX-PMT (volt): 300  
AUX-Gain: 2  
PI-PMT (volt): 530  
PI-Gain: 2  
Discriminator: PI>3 
Gate: single cell  
 
 
 
 
 
 
 
Appendix 
 
97
Appendix 3:  Settings for bivariate flowcytometry 
Flow cytometry: COULTER EPICS XL 
Sheath Speed: middle 
Total cells sampled: 20000 
Maximal running duration: 900 seconds 
Working mode: Manual 
Program: DNA-PI-H3ps10-FITC 
FS-PMT (volt): 55  
FS-Gain: 2  
SS-PMT (volt): 400  
SS-Gain: 1  
AUX-PMT (volt): 300  
AUX-Gain: 2  
Excitation of PI: 488nm  
PI- Filter spectrum: 655-735nm  
PI-PMT (volt): 520  
PI-Gain: 2  
PI signal: Linear  
PI-GATE: single cell  
Discriminator: PI>3  
Excitation of FITC: 488nm  
FITC Filter: 490-550nm  
FITC-PMT (volt): 520  
FITC-Gain: 2  
FITC signal: Logarithmic  
FITC-GATE: FITC positive  
Appendix 
Appendix 4:  Chromatid breaks and exchanges in CHO cells irradiated with 1Gy 
X-rays (arrows represent chromatid breaks and arrow heads represent chromatid 
exchanges) 
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Appendix 
Appendix 5:  Chromatid breaks in human cells irradiated with 1Gy X-rays (arrows 
represent chromatid breaks) 
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